Dermatophytosis

AB1_DERMATOPHYTOSIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B35 Hospital discharge: ICD-9 — 110 Hospital discharge: ICD-8 — 110 Cause of death: ICD-10 — B35 Cause of death: ICD-9 — 110 Cause of death: ICD-8 — 110 2 out of 7 registries used, show all original rules.	5219
4. Check minimum number of events None	5219
5. Include endpoints None	5219
6. Filter based on genotype QC (FinnGen only)	5219

Control definitions (FinnGen only)

Control exclude: AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_DERMATOPHYTOSIS
CONTROL_EXCLUDE	AB1_MYCOSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B35
HD_ICD_9	110
HD_ICD_8	110
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B35
COD_ICD_9	110
COD_ICD_8	110
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dermatophytosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36369	15440	20714
Only index persons	32219	13723	18496
Unadjusted period prevalence (%)
Whole population	0.52	0.44	0.58
Only index persons	0.62	0.50	0.71
Median age at first event (years)
Whole population	54.08	55.94	52.65
Only index persons	53.56	55.39	52.20

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5219	2228	2991
Unadjusted period prevalence (%)	1.08	0.76	1.32
Median age at first event (years)	57.42	55.45	58.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4649: Matched controls
46487

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D01BA02

ATC

terbinafine; oral; topical

5.6

323.0

2451

7728

B35.3

ICD-10 Finland

Tinea pedis

50.3

323.0

1819

586

B35.1

ICD-10 Finland

Tinea unguium

29.1

323.0

1865

1045

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

19.7

309.2

481

271

D01AE16

ATC

amorolfine; topical

4.6

275.6

1097

2900

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.8

266.4

1367

4559

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

3.4

257.5

1655

6573

B35.4

ICD-10 Finland

Tinea corporis

28.4

240.6

333

126

E0000UV

ATC

2.7

217.1

2259

11991

D01AE15

ATC

terbinafine; topical

4.8

184.5

681

1608

D07AC01

ATC

betamethasone; topical

2.5

176.0

1993

10688

11006

ICD-8 Finland

Dermatophytosis, Pedis

+∞

171.9

164

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.9

167.4

776

2265

TQW80

NOMESCO Finland

Local dermatologic skincare

8.4

162.9

376

479

A46

ICD-10 Finland

Erysipelas

2.8

123.8

922

3742

B35.2

ICD-10 Finland

Tinea manuum

74.9

121.1

138

J02AC02

ATC

itraconazole; systemic

2.5

106.4

997

4579

E000001

ATC

2.4

105.3

1125

5528

L30.3

ICD-10 Finland

Infective dermatitis

5.3

100.6

325

647

D01AC02

ATC

miconazole; topical

3.2

97.8

565

1910

D07AC13

ATC

mometasone; topical

2.1

96.1

1486

8575

B35.9

ICD-10 Finland

Dermatophytosis, unspecified

32.9

94.4

125

D07XC01

ATC

betamethasone, combinations; topical

2.7

93.9

754

3153

D07AD01

ATC

clobetasol; topical

2.5

91.6

865

3953

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

86.8

827

3784

J01DB01

ATC

cefalexin; oral

2.1

85.0

3786

31639

1104A

ICD-9 Finland

Dermatophytosis, Of foot

+∞

83.6

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.0

82.3

534

1945

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

80.7

1356

7972

XQ848

NOMESCO Finland

Dermatological photography

5.6

78.1

241

453

H02AB06

ATC

prednisolone; systemic

1.8

77.7

2181

15307

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

76.0

2111

14731

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.8

71.2

320

880

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.9

68.8

236

500

D07BC01

ATC

betamethasone and antiseptics; topical

2.3

67.3

679

3163

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.3

66.3

679

3184

S18

ICPC

Laceration/cut

1.7

65.0

1987

14045

D02AE01

ATC

carbamide; topical

2.9

63.9

415

1500

L57.0

ICD-10 Finland

Actinic keratosis

2.5

63.9

551

2362

B35.0

ICD-10 Finland

Tinea barbae and tinea capitis

87.6

62.0

J01FF01

ATC

clindamycin; systemic

1.8

59.4

1296

8182

D07AB08

ATC

desonide; topical

2.4

59.0

561

2524

1101A

ICD-9 Finland

Dermatophytosis, Of nail

+∞

58.4

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

57.6

721

3689

R4180

NOMESCO Finland

Podiatric therapy

8.5

57.4

129

156

B35.8

ICD-10 Finland

Other dermatophytoses

23.8

57.2

SPAT1301

SPAT

No procedures

1.7

54.7

1477

9919

D01AC03

ATC

econazole; topical

2.8

54.4

370

1375

J01DA01

ATC

[U] cefalexin; systemic

1.6

54.0

2777

22197

SPAT1263

SPAT

Sampling

1.6

53.7

1918

13920

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.4

53.3

477

2076

J02AC01

ATC

fluconazole; systemic

1.7

53.1

1547

10597

E000003

ATC

3.3

53.1

282

884

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

53.0

554

2605

11007

ICD-8 Finland

Dermatophytosis, Unguium

+∞

52.2

C03CA01

ATC

furosemide; systemic

1.7

51.8

1309

8587

L30.0

ICD-10 Finland

Nummular dermatitis

3.7

51.4

239

675

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

51.3

570

2754

L84

ICD-10 Finland

Corns and callosities

3.7

50.2

231

646

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

49.2

242

715

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.2

49.1

157

308

11004

ICD-8 Finland

Dermatophytosis, Inguinis

+∞

49.0

N02AX02

ATC

tramadol; systemic, rectal

1.6

48.8

1914

14122

L30.4

ICD-10 Finland

Erythema intertrigo

7.1

48.8

123

178

E000002

ATC

2.2

48.7

542

2619

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

48.6

416

1764

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

47.8

1354

9138

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.3

45.7

477

2234

D07CC01

ATC

betamethasone and antibiotics; topical

2.0

45.4

617

3244

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.5

45.3

227

680

L04AA06

ATC

mycophenolic acid; systemic

5.3

45.2

143

277

L04AX01

ATC

azathioprine; systemic

3.1

44.1

263

892

S97

ICPC

Chronic ulcer skin

2.7

43.2

316

1224

L85.89

ICD-10 Finland

Other specified epidermal thickening

24.7

43.2

D05AX52

ATC

calcipotriol, combinations; topical

2.7

42.7

318

1246

N02BE01

ATC

paracetamol; systemic, rectal

1.7

42.5

3813

33930

B07.9

ICD-10 Finland

Verruca simplex

3.6

41.5

198

571

D07AA02

ATC

hydrocortisone; topical

2.0

41.0

602

3252

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

40.5

1270

8730

D05BB02

ATC

acitretin; oral

3.9

40.4

172

451

H02AB04

ATC

methylprednisolone; systemic

1.9

40.3

652

3654

ZXC50

NOMESCO Finland

Cryotherapy

3.6

39.9

190

547

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

39.5

288

1114

P01BA02

ATC

hydroxychloroquine; oral

2.3

39.4

377

1689

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

39.4

624

3465

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

39.3

1362

9593

D09AB01

ATC

zinc bandage without supplements; topical

4.5

38.9

143

326

UJF32

NOMESCO Finland

Coloscopy

1.6

37.6

1122

7583

S29

ICPC

Skin symptom/complaint other

1.8

37.5

742

4446

R06AE07

ATC

cetirizine; oral

1.5

37.1

1736

13093

R50.9

ICD-10 Finland

Fever, unspecified

1.9

37.0

634

3617

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

4.1

36.7

147

365

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

36.6

625

3561

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

3.8

36.0

157

421

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

35.9

930

6038

L17

ICPC

Foot/toe symptom/complaint

1.6

35.8

1069

7213

127

Kela drug reimbursment

Transplant complication

4.9

35.6

119

246

XQ802

NOMESCO Finland

Epicutan test

3.0

35.5

210

710

J01MA02

ATC

ciprofloxacin; systemic

1.5

35.5

1673

12598

M79.6

ICD-10 Finland

Pain in limb

1.5

35.5

1477

10810

L30.8

ICD-10 Finland

Other specified dermatitis

3.9

35.5

151

396

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.7

35.4

140

E000006

ATC

2.3

35.3

334

1486

SPAT1312

SPAT

General health counselling

1.6

35.3

1365

9824

E000007

ATC

2.6

35.0

270

1078

A07EC01

ATC

sulfasalazine; oral, rectal

2.2

34.5

381

1823

R60.0

ICD-10 Finland

Localized oedema

2.0

34.2

499

2677

L85.3

ICD-10 Finland

Xerosis cutis

6.5

34.1

140

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

33.6

407

2027

SPAT1310

SPAT

Counselling related to known health issue

1.5

33.4

1358

9860

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.2

33.1

372

1793

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

33.0

1676

12767

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.3

32.8

103

199

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

32.8

220

809

B35

ICD-10 Finland

Dermatophytosis

8.3

32.6

D01AC07

ATC

tioconazole; topical

2.8

32.5

213

770

SPAT1153

SPAT

Removal of sutures

1.5

32.4

1405

10329

R06.0

ICD-10 Finland

Dyspnoea

1.6

32.2

1053

7242

A02BC02

ATC

pantoprazole; systemic

1.4

31.7

2761

23374

SPAT1260

SPAT

Consultation of another employee

1.7

31.6

780

4970

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

31.2

421

2191

L04AD01

ATC

ciclosporin; systemic

4.2

31.2

122

297

XQ845

NOMESCO Finland

Dermatoscopy

5.3

31.2

186

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

31.1

731

4593

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

31.0

331

1558

L04AA01

ATC

[U] ciclosporin; systemic

4.7

31.0

107

230

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

30.8

417

2170

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

3.9

30.6

130

341

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

30.5

725

4566

B35.5

ICD-10 Finland

Tinea imbricata

+∞

30.2

ICD-10 Finland

3.4

30.1

149

444

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.6

29.7

139

396

Z94.0

ICD-10 Finland

Kidney transplant status

5.6

29.6

160

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

29.6

1671

12931

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.7

29.4

208

789

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

29.4

721

4580

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

29.2

1140

8146

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

29.2

357

1784

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

29.1

218

857

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

29.0

684

4297

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.1

28.9

161

524

M54.5

ICD-10 Finland

Low back pain

1.5

28.5

1296

9571

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

28.3

471

2648

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

28.3

510

2946

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

28.2

1387

10407

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

28.1

1348

10063

N03AX16

ATC

pregabalin; oral

1.6

28.1

971

6737

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

27.9

660

4143

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

27.9

1527

11706

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

27.9

988

6891

L20.0

ICD-10 Finland

Besnier prurigo

2.3

27.5

267

1201

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

27.4

2869

24779

R03AC02

ATC

salbutamol; inhalant

1.4

27.3

2093

17086

G47.3

ICD-10 Finland

Sleep apnoea

1.6

26.9

941

6537

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

26.9

291

1378

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

26.5

470

2694

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

26.5

426

2363

L28.0

ICD-10 Finland

Lichen simplex chronicus

5.7

26.3

134

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

4.3

26.0

227

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.0

25.8

355

1856

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

25.8

502

2965

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.2

25.6

137

434

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

25.5

2118

17459

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

25.4

527

3176

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

25.1

779

5246

S74

ICPC

Dermatophytosis

3.7

25.1

113

313

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

3.4

24.9

124

373

M25.5

ICD-10 Finland

Pain in joint

1.5

24.7

1071

7787

J01FA06

ATC

roxithromycin; oral

1.4

24.6

1601

12610

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

24.3

1744

13968

D02AX

ATC

Other emollients and protectives

2.9

24.2

151

531

SPAT1254

SPAT

Administration of medicine

1.7

24.2

611

3897

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

4.7

24.1

175

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

24.0

632

4076

QDH00

NOMESCO Finland

Avulsion of toe nail

13.8

24.0

N05BB01

ATC

hydroxyzine; systemic

2.2

24.0

253

1184

N03AX12

ATC

gabapentin; oral

1.6

23.9

622

4000

XQ899

NOMESCO Finland

Other assessment of skin

8.2

23.8

S76

ICPC

Skin infection other

2.3

23.8

231

1039

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.3

23.5

227

1020

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

23.4

318

1655

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

23.4

332

1758

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

23.3

619

3999

L04AA13

ATC

leflunomide; oral

3.1

23.1

128

416

D05AX02

ATC

calcipotriol; topical

2.4

23.1

202

862

ZX120

NOMESCO Finland

Intravenous

1.8

23.0

403

2297

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

23.0

1868

15239

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.6

22.9

175

693

M04AA01

ATC

allopurinol; systemic

1.7

22.9

568

3601

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.1

22.8

261

1267

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

22.6

1564

12400

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

120.6

22.6

K02.1

ICD-10 Finland

Caries of dentine

1.4

22.6

2250

18966

XQ800

NOMESCO Finland

Prick test

2.0

22.4

290

1481

AA1AD

NOMESCO Finland

CT of head and brain

1.5

22.3

970

7032

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.1

22.1

127

423

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.8

22.1

373

2098

L28.1

ICD-10 Finland

Prurigo nodularis

7.1

22.0

SPAT1325

SPAT

Vaccination

1.4

22.0

1401

10930

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

21.7

1888

15530

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.3

21.7

125

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.5

21.7

117

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

21.6

268

1343

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.0

21.5

130

448

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

21.4

156

606

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

4.2

21.3

199

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

9.2

21.2

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

21.2

261

1305

L82

ICD-10 Finland

Seborrhoeic keratosis

1.6

21.1

610

4018

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

21.1

1153

8734

J01AA02

ATC

doxycycline; systemic

1.4

20.9

3246

29190

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

20.9

229

1088

WZA90

NOMESCO Finland

Other doctors statement

1.5

20.9

897

6479

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.8

20.7

402

2371

A10AE04

ATC

insulin glargine; parenteral

1.8

20.6

408

2420

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

20.4

284

1493

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.0

20.3

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

20.3

1466

11653

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

20.3

666

4529

A02BC03

ATC

lansoprazole; oral

1.4

20.2

1160

8857

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

20.2

2517

21807

SPAT1229

SPAT

Assessment of need for aid

1.8

20.1

342

1932

T89

ICPC

Diabetes insulin dependent

2.4

19.9

173

739

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

19.8

389

2301

WX110

NOMESCO Finland

Local anesthesy

1.3

19.7

2794

24636

S22

ICPC

Nail symptom/complaint

2.0

19.7

250

1268

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

19.7

850

6135

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

19.6

247

1247

S21

ICPC

Skin texture symptom/complaint

1.6

19.5

492

3127

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

19.5

1317

10334

B01AA03

ATC

warfarin; systemic

1.5

19.4

839

6059

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.9

19.3

273

1442

B37.2

ICD-10 Finland

Candidiasis of skin and nail

6.8

19.2

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.3

19.2

302

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

19.1

1080

8207

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

19.1

748

5289

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

19.0

120

426

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

19.0

281

1510

11009

ICD-8 Finland

Dermatophytosis, Unspecified

+∞

18.8

A10AE05

ATC

insulin detemir; parenteral

2.0

18.7

249

1286

M10.9

ICD-10 Finland

Gout, unspecified

1.9

18.7

296

1629

SPAT1262

SPAT

Handing over of treatment supplies

1.5

18.7

766

5466

N02AA05

ATC

oxycodone; systemic

1.6

18.6

580

3888

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

18.6

2159

18408

KMAK

NOMESCO Finland

1.3

18.6

1990

16767

L60.9

ICD-10 Finland

Nail disorder, unspecified

4.0

18.6

191

M48.0

ICD-10 Finland

Spinal stenosis

1.6

18.5

479

3065

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.9

18.5

112

388

D06BB10

ATC

imiquimod; topical

2.2

18.4

187

861

L60.0

ICD-10 Finland

Ingrowing nail

2.2

18.3

184

843

SPAT1255

SPAT

Intravenous administration of medicine

1.9

18.3

278

1508

J01CA04

ATC

amoxicillin; systemic

1.3

18.3

3337

30376

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

2.3

18.3

176

792

M05BA04

ATC

alendronic acid; oral

1.9

18.2

290

1599

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.7

18.2

129

494

SPAT1216

SPAT

Assessment of functional ability

1.5

18.1

611

4175

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.5

18.0

145

595

RJ411

NOMESCO Finland

6.4

18.0

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.8

18.0

117

426

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

18.0

1979

16715

H13

ICPC

Plugged feeling ear

1.5

17.8

723

5144

C07AB07

ATC

bisoprolol; oral

1.3

17.8

1919

16147

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

17.7

806

5863

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

17.7

2406

20922

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

17.7

417

2601

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

17.6

1049

8032

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

17.4

348

2066

B01AB05

ATC

enoxaparin; parenteral

1.4

17.4

1191

9336

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.5

17.3

138

564

L29.9

ICD-10 Finland

Pruritus, unspecified

2.9

17.3

107

377

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

17.3

283

1578

H02AB07

ATC

prednisone; oral

1.6

17.1

536

3596

R53

ICD-10 Finland

Malaise and fatigue

1.5

17.1

761

5512

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

17.0

280

1561

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

17.0

1105

8581

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.8

16.9

113

417

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

16.9

1147

8969

S06

ICPC

Rash localized

2.0

16.8

221

1138

X58

ICD-10 Finland

Exposure to other specified factors

1.5

16.7

535

3606

A02BC01

ATC

omeprazole; systemic

1.4

16.6

1067

8263

E000004

ATC

3.0

16.6

318

A10AA01

ATC

2.6

16.4

122

481

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

16.4

226

1183

-1

NOMESCO Finland

1.4

16.4

1228

9750

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

16.3

107

392

J01MA12

ATC

levofloxacin; systemic

1.5

16.3

731

5297

Z00.0

ICD-10 Finland

General medical examination

1.5

16.3

711

5126

A10AA02

ATC

2.3

16.2

149

658

L04AB04

ATC

adalimumab; parenteral

3.1

16.1

281

N05AH04

ATC

quetiapine; oral

1.5

16.1

585

4057

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.6

16.0

115

443

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.2

15.9

256

L43.9

ICD-10 Finland

Lichen planus, unspecified

3.1

15.9

289

N06AX11

ATC

mirtazapine; oral

1.4

15.9

1172

9273

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

15.9

2797

25023

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.0

15.7

101

J01CF05

ATC

flucloxacillin; systemic

2.2

15.6

161

749

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

15.6

145

644

A07AA02

ATC

nystatin; oral

1.9

15.5

235

1276

J46

ICD-10 Finland

Status asthmaticus

2.6

15.5

112

435

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

15.4

1484

12211

A10AE06

ATC

insulin degludec; parenteral

2.4

15.4

131

556

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

15.3

243

1341

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

15.2

276

1593

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.9

15.2

316

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.8

15.1

285

1662

A06AD11

ATC

lactulose; oral

1.5

15.0

539

3723

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

15.0

506

3445

TK800

NOMESCO Finland

Hemodialysis

2.6

15.0

107

414

J01MA14

ATC

moxifloxacin; systemic

1.7

14.9

334

2051

137

Kela drug reimbursment

Uraemia requiring dialysis

4.4

14.9

121

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

14.9

440

2907

L28

ICPC

Limited function/disability (L)

1.5

14.9

591

4175

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

14.8

549

3818

EBA00

NOMESCO Finland

Extraction of tooth

1.3

14.8

1246

10044

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

14.8

2198

19151

L03

ICPC

Low back symptom/complaint

1.4

14.8

859

6524

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

14.7

365

2307

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

14.7

989

7693

L43.8

ICD-10 Finland

Other lichen planus

3.1

14.7

261

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

14.6

192

988

J01FA10

ATC

azithromycin; systemic

1.3

14.6

2168

18871

R42

ICD-10 Finland

Dizziness and giddiness

1.4

14.5

796

5978

M01CB01

ATC

sodium aurothiomalate; parenteral

3.4

14.5

209

M07.3

ICD-10 Finland

Other psoriatic arthropathies

3.6

14.5

183

J01AA07

ATC

tetracycline; systemic

1.5

14.5

514

3540

Z71.8

ICD-10 Finland

Other specified counselling

1.4

14.5

841

6385

R03BB04

ATC

tiotropium bromide; inhalant

1.6

14.5

379

2428

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

14.4

249

1414

A02BA02

ATC

ranitidine; systemic

1.4

14.4

752

5598

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

14.3

297

1783

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

14.3

322

1983

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

14.2

288

1719

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

14.2

201

1064

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

14.2

155

740

C08CA01

ATC

amlodipine; oral

1.3

14.2

1407

11596

A12AA04

ATC

calcium carbonate; oral

3.0

14.2

262

H04AA01

ATC

glucagon; nasal, parenteral

2.6

14.1

100

384

B86

ICD-10 Finland

Scabies

3.1

14.0

242

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.8

14.0

153

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

13.9

506

3503

E66.8

ICD-10 Finland

Other obesity

2.0

13.9

184

950

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

13.9

121

519

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.8

13.9

318

L73.8

ICD-10 Finland

Other specified follicular disorders

4.0

13.8

140

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

13.8

567

4030

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

13.8

1076

8557

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

13.8

294

1783

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

13.8

250

1442

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.3

13.7

126

555

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

13.7

120

516

H02AB09

ATC

hydrocortisone; systemic

2.6

13.6

381

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

13.6

188

990

SPAT1101

SPAT

Orthostatic test

2.0

13.6

175

896

SPAT1058

SPAT

PEF monitoring instruction

1.7

13.5

309

1910

JN4AD

NOMESCO Finland

Body CT examination

1.7

13.5

299

1831

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

6.3

13.5

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

13.4

333

2105

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

13.4

287

1739

J05AB01

ATC

aciclovir; systemic

1.4

13.4

725

5426

A01

ICPC

Pain general/multiple sites

1.7

13.4

268

1596

L40.8

ICD-10 Finland

Other psoriasis

4.4

13.3

107

J05AB11

ATC

valaciclovir; oral

1.5

13.3

450

3067

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

13.3

638

4674

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

13.3

691

5136

RJ421

NOMESCO Finland

6.6

13.2

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

13.2

459

3147

WW200

NOMESCO Finland

Immunization

2.3

13.2

117

509

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

13.1

133

617

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

13.1

265

1584

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

6.5

13.0

N06AX21

ATC

duloxetine; oral

1.6

13.0

361

2348

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

13.0

388

2570

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

13.0

156

778

L04AB01

ATC

etanercept; parenteral

3.2

13.0

217

9751

FHL

Nail removal in the operating room or under anesthesia

28.4

12.9

A11CC03

ATC

alfacalcidol; systemic

2.4

12.9

104

431

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.3

12.9

120

532

SPAT1210

SPAT

Application of cast or individual aid

2.0

12.9

163

827

L60.3

ICD-10 Finland

Nail dystrophy

6.4

12.9

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

12.8

564

4061

A02BC05

ATC

esomeprazole; systemic

1.3

12.8

1536

12942

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.1

12.8

138

657

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

12.7

891

6958

SPAT1104

SPAT

Monitoring of emergency patient

1.7

12.7

251

1488

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

3.8

12.6

137

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.8

12.6

137

N06AA09

ATC

amitriptyline; systemic

1.6

12.6

357

2333

A28

ICPC

Limited function/disability NOS

1.4

12.6

540

3871

R03DC03

ATC

montelukast; oral

1.4

12.5

541

3879

WX290

NOMESCO Finland

Other blockade of nerve

1.3

12.5

1589

13475

1103A

ICD-9 Finland

Dermatophytosis, Of groin and perianal area

+∞

12.5

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

12.5

232

1351

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

12.5

896

7019

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

12.5

235

1373

Z08

ICPC

Social welfare problem

3.3

12.4

191

SPAT1240

SPAT

Therapeutic discussion

1.6

12.4

336

2169

ZZA00

NOMESCO Finland

Split skin graft

2.2

12.4

128

598

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

12.4

135

646

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

12.3

322

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.0

12.3

231

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

12.3

504

3575

SPAT1097

SPAT

Recording of ECG

1.4

12.3

566

4108

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.6

12.3

348

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

12.3

187

1018

L08.0

ICD-10 Finland

Pyoderma

3.8

12.3

136

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.0

12.2

156

795

RJ420

NOMESCO Finland

5.3

12.2

SPAT1211

SPAT

Application of soft bandage

1.6

12.2

335

2176

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

12.2

145

721

R06AX13

ATC

loratadine; oral

1.5

12.1

502

3569

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

12.1

1088

8806

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.5

12.1

370

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

4.3

12.1

104

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

12.1

379

2541

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

4.2

12.0

109

P01AB01

ATC

metronidazole; oral, rectal

1.3

12.0

1415

11870

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

12.0

319

2053

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

12.0

112

501

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

11.9

192

1069

B05DA

ATC

Isotonic solutions

4.5

11.9

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.4

11.9

166

A01AB09

ATC

miconazole; local oral

1.6

11.9

310

1988

L50.8

ICD-10 Finland

Other urticaria

3.0

11.8

221

M79.1

ICD-10 Finland

Myalgia

1.5

11.8

439

3056

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

6.1

11.8

I50.0

ICD-10 Finland

Congestive heart failure

1.7

11.8

269

1663

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.8

11.7

194

1089

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.7

11.7

137

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

11.7

883

6968

N06AB04

ATC

citalopram; systemic

1.4

11.6

756

5824

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.0

11.6

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

11.6

222

1301

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

11.6

871

6861

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

11.6

907

7188

L12.0

ICD-10 Finland

Bullous pemphigoid

4.7

11.6

M03BX02

ATC

tizanidine; oral

1.2

11.6

2368

21171

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

11.5

265

1641

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.7

11.5

295

R06AX27

ATC

desloratadine; oral

1.3

11.5

892

7062

ZXA00

NOMESCO Finland

Right side

1.3

11.5

1017

8205

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.4

11.5

165

SPAT1234

SPAT

Support of social functional capacity

1.8

11.5

190

1066

R01AD08

ATC

fluticasone; nasal

1.3

11.5

1000

8054

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

11.4

1162

9554

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.8

11.4

254

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

11.4

410

2832

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

11.4

849

6682

NHQ40

NOMESCO Finland

Amputation of toe

2.7

11.4

301

R05

ICD-10 Finland

Cough

1.4

11.4

684

5206

L21.0

ICD-10 Finland

Seborrhoea capitis

3.4

11.4

156

SPAT1053

SPAT

Memory test

1.4

11.3

561

4128

R03BA08

ATC

ciclesonide; inhalant

1.6

11.3

282

1785

K07.60

ICD-10 Finland

Snapping jaw

2.0

11.2

150

780

SFA00

NOMESCO Finland

Small filling

1.5

11.2

459

3256

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

5.3

11.1

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

11.1

916

7310

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

2.8

11.1

245

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

11.1

219

1298

D07AB01

ATC

clobetasone; topical

2.2

11.1

116

546

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.8

11.1

123

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

11.1

863

6837

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

11.1

278

1765

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

11.0

284

1814

R52.2

ICD-10 Finland

Other chronic pain

2.1

11.0

120

575

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

11.0

225

1349

R11

ICD-10 Finland

Nausea and vomiting

1.6

11.0

271

1712

D05AX03

ATC

calcitriol; topical

2.9

11.0

233

Z00.8

ICD-10 Finland

Other general examinations

1.6

10.9

260

1627

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

10.9

1506

12849

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

10.9

107

491

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.3

10.9

101

449

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.9

10.9

216

L50.9

ICD-10 Finland

Urticaria, unspecified

2.1

10.9

122

594

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

5.3

10.8

M01AC06

ATC

meloxicam; systemic, rectal

1.3

10.8

1335

11235

R03BA01

ATC

beclometasone; inhalant

1.4

10.8

493

3571

WZC30

NOMESCO Finland

Teaching

1.4

10.8

485

3506

QDH05

NOMESCO Finland

Correction of deformity of toe nail

7.2

10.7

J45

ICD-10 Finland

Asthma

1.5

10.7

322

2138

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.2

10.7

108

501

B37.8

ICD-10 Finland

Candidiasis of other sites

21.5

10.7

T90

ICPC

Diabetes non-insulin dependent

1.3

10.6

890

7116

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

10.6

267

1697

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

10.6

276

1771

B36.0

ICD-10 Finland

Pityriasis versicolor

3.5

10.5

134

A98

ICPC

Health maint/preventive medicine

1.4

10.5

4230

40784

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

10.5

128

642

N05BA04

ATC

oxazepam; oral

1.3

10.5

849

6750

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.7

10.5

119

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

10.5

452

3238

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.0

10.5

123

608

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.5

10.5

330

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

10.4

179

1016

L43.0

ICD-10 Finland

Hypertrophic lichen planus

4.6

10.4

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.9

10.4

154

831

RJ424

NOMESCO Finland

+∞

10.4

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

10.4

315

2094

L20.8

ICD-10 Finland

Other atopic dermatitis

3.6

10.3

126

L30.2

ICD-10 Finland

Cutaneous autosensitization

32.6

10.3

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

10.3

388

2704

R01AD01

ATC

beclometasone; nasal

1.4

10.3

512

3766

R51.80

ICD-10 Finland

Headache

1.4

10.3

480

3492

L93.0

ICD-10 Finland

Discoid lupus erythematosus

5.1

10.3

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.0

10.3

186

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

10.3

186

R01AD12

ATC

fluticasone furoate; nasal

1.3

10.2

977

7946

L88

ICPC

Rheumatoid/seropositive arthritis

2.0

10.2

130

664

ZXC15

NOMESCO Finland

Use of photodynamic technique

2.8

10.2

230

205

Kela drug reimbursment

Chronic hypertension

1.3

10.2

1089

8987

L50.3

ICD-10 Finland

Dermatographic urticaria

2.8

10.2

221

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.0

10.2

187

ND1AE

NOMESCO Finland

Wrist ultrasound examination

6.6

10.2

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.2

10.1

102

474

D82

ICPC

Teeth/gum disease

1.3

10.1

1201

10043

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

10.1

211

1272

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.8

10.1

167

939

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

4.7

10.1

S01

ICPC

Pain/tenderness of skin

1.8

10.1

157

865

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.9

10.1

H3603, E113

ICD-10 Finland

3.4

10.0

140

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.0

10.0

126

641

C08CA02

ATC

felodipine; oral

1.5

10.0

350

2402

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

10.0

168

951

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.3

10.0

366

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

5.1

10.0

L60.8

ICD-10 Finland

Other nail disorders

3.5

10.0

125

L71.8

ICD-10 Finland

Other rosacea

3.0

10.0

193

J01AA04

ATC

lymecycline; systemic

1.4

10.0

428

3062

C10AC01

ATC

colestyramine; oral

2.2

10.0

451

L14

ICPC

Leg/thigh symptom/complaint

1.6

9.9

255

1626

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

9.9

440

3171

B01AC04

ATC

clopidogrel; oral

1.4

9.9

606

4619

C03DA01

ATC

spironolactone; oral

1.5

9.9

380

2663

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

9.8

265

1710

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

9.8

341

2334

L99

ICPC

Musculoskeletal disease other

2.6

9.8

273

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.9

9.8

203

S70.0

ICD-10 Finland

Contusion of hip

2.0

9.8

125

641

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

9.8

942

7667

R96

ICPC

Asthma

1.5

9.8

289

1908

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

9.8

105

503

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.9

9.8

131

684

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.4

9.8

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.7

9.7

187

1101

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.3

9.7

388

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.1

9.7

111

545

N05CF01

ATC

zopiclone; oral

1.3

9.7

1176

9851

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.5

9.7

294

K08.3

ICD-10 Finland

Retained dental root

1.6

9.7

259

1673

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.9

9.7

193

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

9.7

225

1401

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

7.8

9.6

M81.4

ICD-10 Finland

Drug-induced osteoporosis

6.0

9.5

R01AD09

ATC

mometasone; nasal

1.2

9.5

1594

13846

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.2

9.5

455

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.6

9.5

258

1675

N05CD07

ATC

temazepam; oral

1.4

9.5

439

3190

SPAT1043

SPAT

Audiometry

1.4

9.4

380

2688

SBA00

NOMESCO Finland

Microbiological examinations

2.3

9.4

382

D07CB01

ATC

triamcinolone and antibiotics; topical

2.3

9.4

351

M02AA07

ATC

piroxicam; topical

1.2

9.4

1335

11385

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.4

9.4

324

11008

ICD-8 Finland

Dermatophytosis, Alia

+∞

9.4

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

9.4

153

857

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.2

9.4

425

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

9.4

549

4153

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

9.3

641

4974

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

3.9

9.3

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.6

9.3

112

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

9.2

848

6854

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

9.2

235

1498

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.2

9.2

413

SPAT1285

SPAT

Provision of consultation response

1.7

9.2

197

1199

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

9.2

354

2482

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

9.2

476

3529

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

9.1

197

1202

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

4.2

9.1

A07EA06

ATC

budesonide; oral, local oral

2.0

9.1

115

588

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.8

9.1

145

806

A41.8

ICD-10 Finland

Other specified sepsis

2.5

9.1

280

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.5

9.1

280

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

9.1

357

R35

ICD-10 Finland

Polyuria

1.6

9.0

242

1562

TGC00

NOMESCO Finland

Bronchial lavation

2.1

9.0

467

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

9.0

738

5872

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

9.0

232

M01AE02

ATC

naproxen; oral, rectal

1.2

9.0

2120

19037

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.7

8.9

188

1137

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

8.9

132

715

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

8.9

160

925

H3603, E103

ICD-10 Finland

3.1

8.9

154

L95.8

ICD-10 Finland

Other vasculitis limited to skin

5.7

8.9

N30.0

ICD-10 Finland

Acute cystitis

1.4

8.9

420

3063

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

8.8

445

3283

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.1

8.8

155

H3600, E103

ICD-10 Finland

3.1

8.8

155

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

8.8

161

938

C07AB02

ATC

metoprolol; systemic

1.3

8.8

763

6122

D07XB05

ATC

dexamethasone, combinations; topical

2.1

8.8

459

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

8.8

238

1545

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.1

8.7

453

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

8.7

424

3108

XKD00

NOMESCO Finland

Uroflowmetry

1.3

8.6

659

5187

Z01.2

ICD-10 Finland

Dental examination

1.2

8.6

1434

12413

S08

ICPC

Skin colour change

1.7

8.6

173

1035

D06BX01

ATC

metronidazole; topical

1.5

8.6

323

2254

Z94.1

ICD-10 Finland

Heart transplant status

6.1

8.6

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.7

8.6

176

1058

A04

ICPC

Weakness/tiredness general

1.4

8.6

424

3118

R07.3

ICD-10 Finland

Other chest pain

1.5

8.6

321

2238

K59.0

ICD-10 Finland

Constipation

1.7

8.6

181

1099

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.8

8.6

196

RJ422

NOMESCO Finland

9.0

8.5

R03BA05

ATC

fluticasone; inhalant

1.3

8.5

601

4678

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

8.5

162

957

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

8.5

136

761

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

8.4

161

947

H03AA01

ATC

levothyroxine sodium; systemic

1.3

8.4

746

5992

UKC02

NOMESCO Finland

Cystoscopy

1.3

8.4

617

4831

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

8.4

943

7807

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.9

8.4

C05AA08

ATC

fluocortolone; rectal, topical

1.4

8.4

506

3842

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

8.4

579

4495

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

8.4

355

2538

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.2

8.4

367

R03BA02

ATC

budesonide; inhalant

1.3

8.3

581

4514

11299

ICD-8 Finland

Moniliasis

+∞

8.3

1102A

ICD-9 Finland

Dermatophytosis, Of hand

+∞

8.3

11003

ICD-8 Finland

Dermatophytosis, Corporis

+∞

8.3

S99

ICPC

Skin disease other

2.3

8.3

339

J01FA01

ATC

erythromycin; systemic

1.4

8.3

448

3340

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

8.3

358

2564

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.8

8.3

L04AB06

ATC

golimumab; parenteral

3.7

8.3

L60.1

ICD-10 Finland

Onycholysis

3.3

8.3

118

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

8.3

220

1419

WX892

NOMESCO Finland

Monitored bed care

1.5

8.3

286

1963

H26.02

ICD-10 Finland

Presenil cataract

2.0

8.3

492

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

8.2

290

1998

R06AX22

ATC

ebastine; oral

1.3

8.2

531

4077

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

8.2

633

4988

L73.2

ICD-10 Finland

Hidradenitis suppurativa

3.8

8.2

K07

ICPC

Swollen ankles/oedema

1.7

8.2

150

875

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

8.2

167

1004

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

8.2

1399

12136

L71.9

ICD-10 Finland

Rosacea, unspecified

2.2

8.1

370

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

6.0

8.1

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

5.7

8.1

SPAT1252

SPAT

Overall medication plan or its review

1.5

8.1

255

1714

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

8.1

212

1362

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

8.1

221

1435

R02

ICPC

Shortness of breath/dyspnoea

1.4

8.1

402

2957

Z94.2

ICD-10 Finland

Lung transplant status

6.8

8.0

N05AA02

ATC

levomepromazine; systemic

1.7

8.0

147

857

L70.0

ICD-10 Finland

Acne vulgaris

2.4

8.0

262

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.5

8.0

237

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

8.0

510

3910

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

6.3

8.0

R03AC03

ATC

terbutaline; inhalant

1.4

8.0

457

3446

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

8.0

223

1459

J01CR50

ATC

combinations of penicillins; systemic

7.2

7.9

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

3.3

7.9

117

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.6

7.9

203

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.1

7.9

416

N06AB03

ATC

fluoxetine; oral

1.4

7.9

404

2987

H26.3

ICD-10 Finland

Drug-induced cataract

3.8

7.9

R13

ICD-10 Finland

Dysphagia

1.6

7.9

218

1422

NH3BG

NOMESCO Finland

MRI of foot

3.7

7.9

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

7.9

156

930

ZX108

NOMESCO Finland

Inhalation

3.3

7.9

112

B03XA02

ATC

darbepoetin alfa; parenteral

2.2

7.9

337

M01AH02

ATC

rofecoxib; oral

1.4

7.9

462

3497

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

7.9

359

2601

L13

ICPC

Hip symptom/complaint

1.3

7.9

509

3911

R03DA04

ATC

theophylline; systemic, rectal

1.7

7.8

171

1051

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

7.8

244

1635

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

7.8

109

581

N06AX16

ATC

venlafaxine; oral

1.4

7.8

422

3152

H26.2

ICD-10 Finland

Complicated cataract

2.6

7.8

199

A02BX02

ATC

sucralfate; oral

1.7

7.8

143

836

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.7

7.8

186

WQ020

NOMESCO Finland

9.4

7.8

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.5

7.8

251

1699

C09AA02

ATC

enalapril; systemic

1.3

7.8

736

5965

L29.8

ICD-10 Finland

Other pruritus

2.9

7.8

147

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.9

7.7

113

614

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

7.7

124

693

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.7

7.7

142

829

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

7.7

152

906

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.5

7.7

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

7.6

315

2239

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.4

7.6

268

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

7.6

123

687

C08CA05

ATC

nifedipine; systemic

1.5

7.6

221

1458

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.3

7.6

288

R05

ICPC

Cough

1.3

7.6

744

6048

G04BD08

ATC

solifenacin; oral

1.5

7.6

222

1468

D11AH01

ATC

tacrolimus; topical

3.3

7.6

105

J01FA09

ATC

clarithromycin; systemic

1.2

7.6

1074

9120

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

7.6

186

1179

J04BA02

ATC

dapsone; oral

4.2

7.6

WX213

NOMESCO Finland

Lower leg blockade

3.1

7.6

127

M01AX05

ATC

glucosamine; oral

1.3

7.6

687

5534

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.3

7.6

271

V03AE01

ATC

polystyrene sulfonate; oral

2.6

7.6

208

S09

ICPC

Infected finger/toe

1.9

7.6

105

560

A10BH01

ATC

sitagliptin; oral

1.4

7.5

338

2440

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.6

7.5

174

1085

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

7.5

904

7536

D07AC14

ATC

methylprednisolone aceponate; topical

1.7

7.5

152

913

S19

ICPC

Skin injury other

1.7

7.5

142

839

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

7.5

432

K83.0

ICD-10 Finland

Cholangitis

2.5

7.5

228

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.9

7.5

106

568

WQ021

NOMESCO Finland

7.1

7.5

Z49.2

ICD-10 Finland

Other dialysis

3.5

7.5

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.0

7.4

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

7.4

274

1905

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.0

7.4

129

R06.5

ICD-10 Finland

Mouth breathing

1.4

7.4

309

2200

B02

ICD-10 Finland

Zoster [herpes zoster]

1.8

7.4

121

680

ZXA05

NOMESCO Finland

Left side

1.2

7.4

935

7835

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.0

7.4

437

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.4

593

4700

S17

ICPC

Abrasion/scratch/blister

2.1

7.4

413

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.4

7.4

260

H02AB08

ATC

triamcinolone; systemic

4.5

7.4

M01AX17

ATC

nimesulide; oral

1.2

7.4

872

7256

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

7.4

231

1551

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

7.3

984

8300

N06AA12

ATC

doxepin; systemic

1.6

7.3

179

1134

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

3.7

7.3

A05

ICPC

Feeling ill

1.6

7.3

174

1095

03599

ICD-8 Finland

Erysipelas

4.3

7.3

L85.1

ICD-10 Finland

Acquired keratosis [keratoderma] palmaris et plantaris

8.4

7.3

C02AC05

ATC

moxonidine; oral

1.6

7.3

162

999

B01AB04

ATC

dalteparin; parenteral

1.6

7.3

167

1039

11005

ICD-8 Finland

Dermatophytosis, Manuum

+∞

7.3

RJ413

NOMESCO Finland

+∞

7.3

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

7.3

145

869

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

7.3

155

945

N03AE01

ATC

clonazepam; systemic

1.6

7.3

194

1258

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

7.2

746

6105

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.1

7.2

372

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.5

7.2

234

1582

NHG82

NOMESCO Finland

Fusion of other tarsal joint

3.0

7.2

126

M01AH05

ATC

etoricoxib; oral

1.2

7.2

2203

20095

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

7.2

136

804

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.4

7.2

257

C10AA05

ATC

atorvastatin; oral

1.2

7.2

1454

12783

M01CB03

ATC

auranofin; oral

3.2

7.2

110

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.4

7.2

228

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

7.2

164

1020

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

7.2

282

1986

J02AB02

ATC

ketoconazole; oral

1.9

7.2

507

H3601, E103

ICD-10 Finland

2.9

7.1

141

Q82.82

ICD-10 Finland

Inherited keratosis palmaris et plantaris

30.0

7.1

S75

ICPC

Moniliasis/candidiasis skin

3.6

7.1

NH3CG

NOMESCO Finland

Extensive MRI of foot

3.8

7.1

S87

ICPC

Dermatitis/atopic eczema

2.1

7.1

346

SPAT1151

SPAT

Treatment of major wounds

2.5

7.1

214

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.5

7.1

214

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

7.1

445

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.9

7.1

143

R06AE09

ATC

levocetirizine; oral

1.3

7.1

456

3501

S22.3

ICD-10 Finland

Fracture of rib

1.5

7.1

232

1574

B37.08

ICD-10 Finland

Other candidal stomatitis

5.3

7.1

L01BB01

ATC

6.0

7.1

C10AA03

ATC

pravastatin; oral

1.5

7.1

248

1708

K05.30

ICD-10 Finland

Periodontitis complex

1.3

7.1

426

3236

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

5.6

7.0

S06.0

ICD-10 Finland

Concussion

1.4

7.0

338

2475

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

7.0

423

3211

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

10.0

7.0

G04BD12

ATC

mirabegron; oral

1.4

7.0

335

2447

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.0

1565

13878

J01EA01

ATC

trimethoprim; systemic

1.3

7.0

773

6375

A10BH05

ATC

linagliptin; oral

1.6

7.0

164

1028

K51.5

ICD-10 Finland

Left sided colitis

1.9

7.0

466

L04AA17

ATC

[U] adalimumab; parenteral

4.7

7.0

J01MA06

ATC

norfloxacin; oral

1.3

7.0

420

3192

C09AA05

ATC

ramipril; oral

1.2

7.0

926

7797

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.2

7.0

107

J01XC01

ATC

fusidic acid; systemic

2.4

7.0

237

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

7.0

797

6603

ZXA10

NOMESCO Finland

Bilateral

1.3

7.0

647

5224

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.2

7.0

309

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.4

6.9

219

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

3.8

6.9

V03AE02

ATC

sevelamer; oral

3.8

6.9

L73.9

ICD-10 Finland

Follicular disorder, unspecified

4.4

6.9

N05BA01

ATC

diazepam; systemic, rectal

1.3

6.9

447

3433

S80.0

ICD-10 Finland

Contusion of knee

1.6

6.9

193

1263

C01DA14

ATC

isosorbide mononitrate; oral

1.3

6.9

543

4288

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

6.9

100

543

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.7

6.9

138

827

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.4

6.9

231

AN1

Coronary angiography

1.3

6.9

444

3411

N05AF03

ATC

chlorprothixene; systemic

1.9

6.9

501

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

6.9

263

1845

A10BJ02

ATC

liraglutide; parenteral

2.0

6.9

422

H26.4

ICD-10 Finland

After-cataract

1.4

6.9

274

1937

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

6.9

103

564

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

4.0

6.9

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

1.9

6.9

464

C08CA13

ATC

lercanidipine; oral

1.3

6.8

452

3483

J20

ICD-10 Finland

Acute bronchitis

1.4

6.8

301

2168

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

1.9

6.8

480

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.6

6.8

172

L71.0

ICD-10 Finland

Perioral dermatitis

3.0

6.8

126

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.3

6.8

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

6.8

402

P20

ICPC

Memory disturbance

1.3

6.8

401

3038

N18.8

ICD-10 Finland

Other chronic renal failure

1.8

6.8

541

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

3.5

6.8

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.6

6.8

155

967

RJ210

NOMESCO Finland

5.3

6.8

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

5.3

6.8

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.1

6.8

355

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

3.6

6.7

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

3.1

6.7

110

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

3.7

6.7

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.8

6.7

104

577

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.7

510

4009

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

6.7

336

2475

C09CA01

ATC

losartan; oral

1.2

6.7

863

7241

CKC12

NOMESCO Finland

Photocoagulation of retina

1.6

6.7

146

896

M10.3

ICD-10 Finland

Gout due to impairment of renal function

4.1

6.7

QX_2

NOMESCO Finland

Other diagnostic procedures of skin

22.5

6.7

M02AA10

ATC

ketoprofen; topical

1.3

6.6

537

4256

M54.3

ICD-10 Finland

Sciatica

1.5

6.6

188

1237

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.7

6.6

132

795

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

6.6

388

2937

SPD00

NOMESCO Finland

Fitting and preparation of total teeth prosthesis

2.5

6.6

205

D19

ICPC

Teeth/gum symptom/complaint

1.2

6.6

859

7220

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

6.6

216

1468

K74.3

ICD-10 Finland

Primary biliary cirrhosis

4.0

6.6

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

6.6

445

JN4BD

NOMESCO Finland

Extensive body CT

1.3

6.6

386

2922

R21

ICPC

Throat symptom/complaint

1.3

6.6

561

4485

L03.8

ICD-10 Finland

Cellulitis of other sites

3.6

6.6

R05FB02

ATC

cough suppressants and expectorants

1.2

6.5

1365

12011

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

6.5

760

6306

H01.0

ICD-10 Finland

Blepharitis

1.6

6.5

164

1048

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.4

6.5

226

A07EC02

ATC

mesalazine; oral, rectal

1.6

6.5

175

1138

L08

ICPC

Shoulder symptom/complaint

1.3

6.5

635

5160

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

6.8

6.5

RJ511

NOMESCO Finland

6.8

6.5

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.9

6.5

465

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.7

6.5

157

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

6.5

190

1261

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

6.5

168

1080

H61.2

ICD-10 Finland

Impacted cerumen

1.5

6.5

191

1266

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

6.5

173

1124

S10

ICPC

Boil/carbuncle

1.6

6.5

176

1148

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

6.5

100

556

XG466

NOMESCO Finland

Sleep oxymetry

1.7

6.5

118

689

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.0

6.5

374

L13.0

ICD-10 Finland

Dermatitis herpetiformis

3.9

6.5

NHG20

NOMESCO Finland

Fusion of talocrural joint

3.6

6.5

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.1

6.4

326

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.8

6.4

109

624

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

6.4

130

784

NH1AD

NOMESCO Finland

Ankle and foot CT

2.1

6.4

340

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.4

6.4

301

2197

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.0

6.4

404

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

4.2

6.4

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

7.4

6.4

N04BC05

ATC

pramipexole; oral

1.5

6.4

234

1625

H01

ICPC

Ear pain/earache

1.4

6.4

314

2306

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.6

6.4

145

904

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

6.4

107

611

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

6.4

196

1312

B36.8

ICD-10 Finland

Other specified superficial mycoses

4.7

6.4

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

4.7

6.4

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.6

6.3

149

934

R03AC13

ATC

formoterol; inhalant

1.6

6.3

149

934

N03AX09

ATC

lamotrigine; oral

1.7

6.3

134

817

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.5

6.3

226

1564

D01BA01

ATC

griseofulvin; oral; topical

6.5

6.3

L01BB05

ATC

fludarabine; systemic

8.1

6.3

T82

ICPC

Obesity

1.8

6.3

108

621

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.8

6.3

102

575

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

11.0

6.3

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

6.3

303

2219

TAKUU

NOMESCO Finland

2.7

6.3

139

WKPAL

NOMESCO Finland

2.1

6.3

325

C10AA01

ATC

simvastatin; oral

1.2

6.2

1673

15030

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

6.2

113

662

N05AH03

ATC

olanzapine; systemic

1.5

6.2

176

1156

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

6.2

586

4739

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

6.2

1257

11024

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

6.2

164

SPAT1147

SPAT

Destruction of skin lesion with external methods

2.1

6.2

314

L16

ICPC

Ankle symptom/complaint

1.4

6.2

318

2353

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

2.8

6.2

127

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

6.2

123

741

A10BA02

ATC

metformin; oral

1.2

6.2

1025

8822

N02AC04

ATC

dextropropoxyphene; oral

1.7

6.2

126

762

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.7

6.2

126

765

C03AA03

ATC

hydrochlorothiazide; oral

1.4

6.1

325

2418

RJ410

NOMESCO Finland

4.5

6.1

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

2.7

6.1

151

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

5.7

6.1

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

6.1

514

4095

QCH00

NOMESCO Finland

Avulsion of finger nail

7.7

6.1

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

6.1

108

628

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

6.1

790

6626

S04

ICPC

Lump/swelling localized

1.4

6.1

283

2060

N03AG01

ATC

valproic acid; systemic, rectal

1.5

6.1

193

1305

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.4

6.1

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

2.7

6.1

136

G04CA02

ATC

tamsulosin; oral

1.2

6.1

927

7910

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

6.1

220

1529

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.7

6.0

143

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

8.6

6.0

C10AA04

ATC

fluvastatin; oral

1.4

6.0

297

2185

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

6.0

369

2812

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.5

6.0

179

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

2.6

6.0

154

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.6

6.0

161

R10.0

ICD-10 Finland

Acute abdomen

1.8

6.0

102

586

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

6.0

174

1152

207

Kela drug reimbursment

Chronic arrhythmias

1.3

6.0

511

4076

P99

ICPC

Psychological disorders other

2.0

6.0

379

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

10.0

6.0

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.7

6.0

121

730

T78.4

ICD-10 Finland

Allergy, unspecified

1.7

6.0

121

731

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000494) Fungus identified in Specimen by Culture

1690

4920

4.60

307.65

1.7

1.4

—

(3006315) Basophils [#/volume] in Blood

3042

21385

2.01

127.64

8.7

5.8

0.0

e9/l

0.12

2745

18407

(3001604) Monocytes [#/volume] in Blood

3022

21295

2.00

124.72

8.7

5.8

0.6

e9/l

0.20

2728

18299

(3013115) Eosinophils [#/volume] in Blood

3094

22099

1.98

121.38

9.0

6.0

0.2

e9/l

1.57

2820

19303

(3013650) Neutrophils [#/volume] in Blood by Automated count

3358

24695

2.01

120.82

11.8

9.0

4.3

4.2

e9/l

2.61

3070

21457

(3019198) Lymphocytes [#/volume] in Blood

3071

21901

1.98

120.74

8.8

5.8

1.9

e9/l

0.97

2802

19190

(3007853) Bacteria identified in Skin by Aerobe culture

1052

5070

2.35

119.16

2.3

1.8

—

(40761535) Cells panel - Urine sediment

819

3522

2.57

119.10

5.0

3.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1514

9159

1.92

90.64

7.2

4.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2567

18694

1.73

80.19

6.2

5.0

35.0

35.4

g/l

3.21

2426

17416

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3992

33061

1.88

79.01

10.3

7.6

79.9

78.9

u/l

0.51

3800

31163

(40768443) Skin Pathology biopsy report

461

1818

2.68

78.41

1.3

1.2

—

(3023368) Bacteria identified in Blood by Culture

1802

12223

1.72

70.07

5.4

4.4

—

(3019150) Specific gravity of Urine by Refractometry

1417

9011

1.79

68.93

5.8

3.9

1.0

kg/l

0.41

144

1343

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

701

3526

2.14

68.44

2.9

2.7

62.1

65.3

ml/min/173m2

1.22

317

1397

(3013707) Erythrocyte sedimentation rate by Westergren method

3780

31328

1.75

67.92

6.0

4.0

13.3

12.2

mm/h

4.38

3538

28983

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

947

5346

1.94

67.08

12.0

7.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2797

21502

1.65

66.05

8.9

6.9

1.2

mmol/l

2.59

2401

18215

(3029937) Albumin [Presence] in Urine by Test strip

1656

11129

1.71

65.66

6.0

3.9

0.0

estimate

0.19

478

3711

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2584

19493

1.64

65.61

8.1

6.2

1.2

mmol/l

2.30

2356

17714

(3011397) Hemoglobin [Presence] in Urine by Test strip

1480

9697

1.73

64.02

5.3

3.5

—

(3042936) Bacteria identified in Isolate by Culture

1041

6174

1.86

62.93

2.5

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

2667

20517

1.61

60.69

5.1

3.5

0.0

estimate

1.08

475

3804

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2860

22423

1.61

59.77

7.4

6.3

11.2

11.9

umol/l

2.42

2744

21325

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1895

13446

1.64

59.72

3.2

2.6

57.0

58.6

u/l

0.51

1757

12461

(3019069) Monocytes/100 leukocytes in Blood

2622

20138

1.61

59.68

9.5

6.3

8.7

8.8

0.82

2479

18842

(3020891) Body temperature

417

1784

2.45

59.45

6.4

4.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

2659

20535

1.60

58.80

6.3

4.8

0.0

estimate

0.50

481

3903

(3006504) Eosinophils/100 leukocytes in Blood

2605

20026

1.60

58.68

9.1

6.0

2.9

0.41

2454

18651

(3009261) Glucose [Presence] in Urine by Test strip

2683

20794

1.60

58.22

5.2

3.6

0.0

estimate

1.72

461

3740

(3022096) Basophils/100 leukocytes in Blood

2541

19470

1.59

57.66

9.1

6.0

0.7

0.85

2395

18157

(3031040) Bacteria [#/volume] in Urine by Automated count

3383

27745

1.62

57.63

5.6

4.4

312.2

1477.2

e6/l

2.07

409

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1865

13270

1.63

57.59

2.5

2.2

232.7

230.5

u/l

0.02

1761

12457

(3018010) Neutrophils/100 leukocytes in Blood

2629

20353

1.59

56.74

8.8

5.9

57.8

57.5

0.60

2482

19018

(3002030) Lymphocytes/100 leukocytes in Blood

2661

20659

1.59

56.74

9.3

6.1

27.2

27.5

0.47

2501

19219

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2246

16808

1.59

55.68

2.7

2.2

77.1

nmol/l

0.00

2033

15049

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1127

7151

1.73

53.15

2.1

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2119

15811

1.57

52.14

5.5

3.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1559

10840

1.62

51.57

2.6

2.2

3.1

2.9

mg/l

1.56

1355

9273

(3019060) Gas panel - Arterial blood

578

3002

2.04

51.01

5.0

4.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3131

25582

1.56

50.82

6.2

4.8

6.9

6.8

mmol/l

1.36

2954

24038

(3037467) Urinalysis macro (dipstick) panel - Urine

3481

29174

1.58

50.17

5.6

4.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1652

11724

1.60

49.85

3.5

2.7

4124.8

5114.8

umol/l

0.43

1440

10166

(3008152) Bicarbonate [Moles/volume] in Arterial blood

548

2843

2.04

48.40

7.9

6.9

24.6

24.5

mmol/l

0.18

508

2655

(3037522) Nuclear Ab [Titer] in Serum

896

5465

1.77

48.01

1.4

1.3

493.2

502.1

titre

0.05

197

1102

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4679

42559

1.96

47.59

22.6

14.7

25.0

24.9

mg/l

0.14

4020

33970

(3018418) pH of Serum or Plasma

1744

12658

1.57

47.18

5.7

4.1

7.4

0.33

317

2436

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1749

12750

1.56

46.17

3.7

3.1

1609.4

1515.2

ng/l

0.33

1517

10972

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

820

4941

1.78

45.60

2.0

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

687

3929

1.86

45.34

2.6

2.3

5.5

7.9

ug/l

3.37

600

3461

(3003396) Base excess in Arterial blood by calculation

855

5225

1.76

45.27

6.5

7.4

1.2

1.0

mmol/l

0.57

678

4050

(3027801) Oxygen [Partial pressure] in Arterial blood

854

5238

1.75

44.58

6.5

7.4

11.6

12.4

kpa

3.36

819

5001

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

854

5239

1.75

44.55

6.5

7.4

5.1

kpa

0.28

818

5004

(3016502) Oxygen saturation in Arterial blood

784

4696

1.79

44.40

6.6

7.8

95.2

95.6

1.29

756

4526

(3026008) Bacteria identified in Urine by Culture

1671

12170

1.55

43.75

3.7

3.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

903

5673

1.72

43.13

7.2

7.1

103.8

104.5

mmol/l

3.66

878

5547

(42870588) Differential panel, method unspecified - Blood

1948

14705

1.52

43.03

8.4

5.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

924

5853

1.70

42.78

8.6

6.1

1.1

1.0

mmol/l

1.62

860

5455

(3014111) Lactate [Moles/volume] in Serum or Plasma

683

3969

1.83

42.66

5.9

7.3

1.4

mmol/l

0.49

664

3820

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

806

4932

1.75

42.23

1.9

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

563

3094

1.92

41.85

1.7

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2145

16629

1.49

41.09

4.5

3.7

41.1

81.5

ng/l

0.85

1607

11722

(3043409) Potassium [Moles/volume] in Arterial blood

305

1341

2.35

40.64

5.1

4.1

3.9

mmol/l

0.43

288

1252

(3032080) INR in Blood by Coagulation assay

2295

18064

1.48

40.60

12.0

9.6

1.3

inr

0.22

611

5147

(3015377) Calcium [Moles/volume] in Serum or Plasma

1881

14233

1.50

40.38

3.6

3.4

2.3

2.4

mmol/l

0.83

1647

12422

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

118

306

3.92

40.14

1.7

1.5

18.1

21.2

u/ml

0.36

(3022948) Iron [Moles/volume] in Serum or Plasma

1035

6883

1.63

39.34

3.3

2.5

12.4

13.1

umol/l

2.13

961

6411

(3000850) Epithelial cells [#/volume] in Urine

1318

9288

1.56

39.16

3.3

2.6

4.6

4.9

e6/l

0.38

1210

8117

(3010375) cycloSPORINE [Mass/volume] in Blood

178

4.90

39.04

27.6

25.6

100.4

116.1

ug/l

1.45

141

(3002173) Hemoglobin [Mass/volume] in Arterial blood

715

4320

1.76

38.93

7.0

8.2

121.9

g/l

0.02

688

4165

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2212

17453

1.46

37.71

3.5

2.8

144.9

144.1

ug/l

0.05

2057

16133

(3000991) Gas panel - Venous blood

642

3794

1.79

37.64

7.5

8.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3622

31465

1.49

37.11

4.5

3.8

14.9

14.8

pmol/l

1.29

3324

28541

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1299

9227

1.54

36.87

1.9

1.8

1.3

mg/l

0.07

1003

7073

(3015171) Extractable nuclear Ab [Units/volume] in Serum

319

1494

2.21

36.55

1.3

1.2

0.5

1.0

u/ml

1.05

131

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

217

858

2.60

36.34

7.6

5.3

921.3

2422.1

iu/ml

0.38

123

(3019309) Folate [Moles/volume] in Red Blood Cells

1162

8074

1.56

36.33

1.8

1287.4

1160.1

nmol/l

3.47

900

6089

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2213

17583

1.45

35.73

2.2

2.0

93.1

94.4

pmol/l

0.58

1243

9326

(3009445) Proteinase 3 Ab [Units/volume] in Serum

370

1860

2.06

35.29

1.8

1.5

11.0

19.7

u/ml

0.84

(3005719) IgG [Mass/volume] in Serum or Plasma

552

3204

1.81

34.22

3.3

2.6

10.4

10.6

g/l

0.64

516

2915

(40758558) Short blood count panel - Blood

1464

10842

1.49

33.49

8.5

6.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4727

43967

1.80

33.13

24.7

17.1

139.4

139.7

mmol/l

7.54

4646

42895

(3004789) Transferrin [Mass/volume] in Serum or Plasma

945

6388

1.59

32.90

3.3

2.5

2.3

g/l

0.15

877

5947

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1205

8611

1.52

32.64

1.4

1.3

2.3

1.9

u/ml

0.33

351

2246

(3027945) Reticulocytes/100 erythrocytes in Blood

784

5080

1.64

32.47

3.4

2.5

1.8

0.42

690

4497

(3023103) Potassium [Moles/volume] in Serum or Plasma

4734

44092

1.79

32.46

24.8

17.2

4.0

mmol/l

5.80

4645

42954

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

177

669

2.70

32.45

3.4

2.8

701.7

2793.5

u/ml

—

(3017181) Myelocytes/100 leukocytes in Blood

607

3678

1.74

32.37

5.5

4.1

1.0

0.9

0.34

217

1071

(3021960) Folate [Moles/volume] in Serum or Plasma

1362

10001

1.49

32.29

1.7

1.5

19.5

20.2

nmol/l

0.74

1187

8564

(3021447) Carbon dioxide [Partial pressure] in Venous blood

674

4227

1.68

31.63

4.9

3.8

5.9

5.8

kpa

1.06

652

4098

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1033

7186

1.55

31.55

4.5

3.4

0.8

mmol/l

1.16

973

6722

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4226

38331

1.54

31.54

5.4

4.5

1.9

2.1

mu/l

1.27

3903

34970

(3024354) Oxygen [Partial pressure] in Venous blood

574

3452

1.74

31.39

4.3

3.2

4.6

4.7

kpa

0.07

551

3337

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

794

5202

1.62

31.37

4.7

4.3

255.2

243.0

u/l

0.73

754

4930

(3026389) Candida sp identified in Specimen by Organism specific culture

141

482

2.98

31.16

1.4

1.2

—

(3002032) Base excess in Venous blood by calculation

670

4214

1.68

31.07

4.9

3.9

1.9

mmol/l

0.13

550

3400

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

176

683

2.63

30.63

1.6

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

1790

13968

1.43

30.45

3.8

3.2

7.3

7.8

mmol/l

4.27

1547

11737

(3017143) Hepatitis C virus Ab [Presence] in Serum

712

4580

1.64

30.20

1.9

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

393

2130

1.91

30.15

4.2

3.4

25.1

25.2

mmol/l

0.22

384

2060

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

355

1861

1.97

30.05

2.3

1.9

2.8

ug/l

0.02

319

1651

(3012516) Albumin [Mass/volume] in Urine

1704

13215

1.43

29.85

3.8

3.3

602.5

380.2

mg/l

0.93

1200

8562

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

265

1254

2.17

29.55

1.5

1.6

2.3

8.0

iu/ml

0.54

272

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

298

1476

2.08

29.52

1.8

1.6

105.5

293.3

titre

1.69

(3012544) pH of Venous blood

683

4389

1.64

29.01

4.9

3.9

7.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

551

3350

1.72

28.88

5.1

3.9

0.6

0.17

157

770

(3020630) Protein [Mass/volume] in Serum or Plasma

600

3743

1.68

28.57

2.6

65.9

66.4

g/l

0.88

551

3405

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

372

2026

1.90

28.09

4.0

2.7

0.7

0.6

1.81

354

1942

(36304419) Bacteria [Presence] in Urine

1541

11866

1.42

27.60

3.9

3.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

181

4.13

27.35

41.9

33.8

7.3

7.4

ug/l

0.25

163

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

869

5988

1.54

27.29

3.5

2.6

21.3

23.1

4.00

743

5134

(3020682) Albumin/Creatinine [Ratio] in Urine

1762

13915

1.40

27.22

4.5

4.0

11.9

9.7

mg/mmol

0.83

1223

8993

(3028026) IgM [Mass/volume] in Serum or Plasma

436

2522

1.80

27.13

2.0

1.9

1.3

1.4

g/l

0.03

393

2291

(3023520) Reticulocytes [#/volume] in Blood

600

3796

1.66

26.99

3.0

2.6

71.7

69.6

e9/l

0.60

466

2884

(3048689) Calprotectin [Mass/mass] in Stool

716

4739

1.59

26.80

2.6

2.3

170.7

147.5

ug/g

0.60

588

3740

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

375

2080

1.87

26.74

4.0

2.8

1.3

1.2

1.76

375

2066

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4810

45369

1.77

26.66

15.2

10.5

26.7

27.2

u/l

0.93

4686

43735

(3030467) Casts [#/volume] in Urine by Automated count

1573

12232

1.41

26.40

4.0

3.2

0.4

e6/l

0.19

1296

9196

(3018095) Leukocytes [#/volume] in Urine

1910

15353

1.38

26.31

4.5

3.8

106.6

93.6

e6/l

0.20

1495

11006

(3020779) Urea [Moles/volume] in Serum or Plasma

646

4193

1.62

26.20

11.0

7.6

10.6

10.1

mmol/l

0.96

615

3997

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

518

3189

1.69

25.82

5.5

4.0

112.2

93.8

ng/l

2.79

465

2763

(3036481) Cortisol [Moles/volume] in Serum or Plasma

592

3775

1.64

25.76

2.9

2.2

327.8

371.4

nmol/l

6.55

548

3464

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

260

3.47

25.54

1.4

1.3

110.9

73.0

titre

0.71

(3021440) Promyelocytes/100 leukocytes in Blood

557

3505

1.66

25.53

5.6

4.1

0.1

0.2

1.22

183

1004

(3007164) IgA [Mass/volume] in Serum or Plasma

1059

7700

1.47

25.47

1.6

1.5

2.5

g/l

0.07

686

4686

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

271

3.40

25.35

1.4

1.3

951.4

212.7

titre

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

249

1223

2.09

25.22

1.9

1.5

1.2

g/l

0.18

239

1159

(46235355) HIV 1 and 2 tests - Meaningful Use set

924

6554

1.50

25.11

1.9

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

289

1507

1.97

24.80

2.7

2.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4269

39325

1.47

24.48

7.2

5.9

41.2

40.1

mmol/mol

9.64

4000

36381

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2385

20013

1.35

24.46

4.8

4.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

246

1217

2.07

24.44

1.9

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1057

7752

1.46

24.15

3.1

2.5

mmol/l

0.13

933

6795

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

945

6787

1.48

24.03

1.3

40.4

33.5

iu/ml

0.56

296

2088

(3005322) IgE [Units/volume] in Serum or Plasma

413

2451

1.74

23.46

1.4

1.3

561.5

222.1

u/ml

1.95

383

2245

(40761511) CBC panel - Blood by Automated count

4686

44135

1.60

23.09

20.2

13.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

219

1065

2.10

22.78

1.8

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

492

3089

1.65

22.65

2.2

2.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1737

14001

1.36

22.60

4.0

3.2

33.9

36.0

u/l

0.50

1647

13279

(3025941) Bacteria identified in Stool by Culture

380

2229

1.76

22.47

1.4

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

246

1259

2.00

22.27

1.3

—

(3025159) Blasts/100 leukocytes in Blood

515

3287

1.63

22.20

5.6

4.1

0.2

0.3

0.28

161

834

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

234

1178

2.03

22.18

2.0

1.5

0.2

g/l

2.25

225

1112

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

211

1032

2.09

21.63

1.8

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

419

2555

1.70

21.54

1.8

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

441

2726

1.67

21.53

4.1

3.3

129.3

129.4

g/l

0.02

432

2650

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

171

777

2.24

21.12

1.9

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

293

3.07

21.11

2.4

651.3

660.0

e6/l

0.03

122

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1011

7530

1.42

20.88

3.3

2.8

1.3

1.1

e6/l

0.65

702

4297

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

611

4120

1.55

20.78

2.3

0.2

g/l

0.67

556

3837

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

882

6412

1.45

20.77

1.3

1.2

11.0

11.4

u/ml

0.05

360

2457

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

772

5475

1.48

20.64

1.7

1.6

—

(4010399)

473

3014

1.63

20.48

1.5

1.4

—

(44790049)

124

495

2.54

20.47

1.8

1.4

—

(44790047)

124

495

2.54

20.47

1.8

1.4

—

(44806118)

124

495

2.54

20.47

1.8

1.4

—

(44790048)

124

495

2.54

20.47

1.8

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

118

460

2.60

20.45

1.8

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

113

432

2.65

20.37

1.8

1.7

—

(40768804) Tissue Pathology biopsy report

2030

16949

1.32

20.21

2.4

2.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

239

3.26

20.16

3.0

2.7

38.4

37.8

0.07

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

142

610

2.37

20.01

1.8

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

231

1202

1.96

19.96

1.5

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

828

5999

1.45

19.76

35.0

25.7

1.4

inr

0.37

110

871

(3002582) Erythrocytes [#/volume] in Urine

1645

13384

1.33

19.40

4.1

3.3

87.2

87.0

e6/l

0.00

1363

10292

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

178

856

2.12

19.10

1.4

1.2

73.3

203.0

titre

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

102

385

2.68

18.88

1.8

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

102

385

2.68

18.88

1.8

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

102

385

2.68

18.88

1.8

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4467

41978

1.45

18.73

5.3

4.5

4.6

mmol/l

10.41

4160

38891

(3021589) Normoblasts [#/volume] in Blood

2222

18923

1.30

18.67

12.9

9.7

0.0

e9/l

0.42

1894

15443

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4438

41670

1.43

18.56

5.1

4.4

1.4

mmol/l

0.87

4102

38373

(3000963) Hemoglobin [Mass/volume] in Blood

4923

47271

1.73

18.53

32.9

21.6

134.6

136.3

g/l

11.87

4869

46591

(3024731) MCV [Entitic volume]

4921

47256

1.72

18.39

32.6

21.4

91.4

91.1

4.90

4870

46573

(3026361) Erythrocytes [#/volume] in Blood

4921

47260

1.72

18.33

32.7

21.5

4.5

e12/l

10.38

4832

45892

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4394

41204

1.42

18.31

5.3

4.6

6.1

6.0

mmol/l

5.08

4036

37524

(3007461) Platelets [#/volume] in Blood

4919

47237

1.72

18.31

32.7

21.5

245.9

246.1

e9/l

0.09

4844

46002

(3035941) MCH [Entitic mass]

4920

47253

1.72

18.25

32.5

21.4

30.4

0.27

4868

46569

(3010813) Leukocytes [#/volume] in Blood

4921

47269

1.72

18.20

32.8

21.5

7.0

6.8

e9/l

5.42

4835

45893

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4306

40281

1.39

17.82

4.7

4.0

1.4

1.3

mmol/l

3.06

3976

36848

(3044889) 12 lead EKG panel

3364

30358

1.30

17.80

4.7

3.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

275

1573

1.79

17.71

2.7

2.3

556.5

597.3

ug/l

0.08

258

1493

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

445

2903

1.58

17.41

5.0

3.6

5.2

5.1

kpa

1.09

415

2680

(3009343) pH of Capillary blood

439

2862

1.58

17.22

5.0

3.6

7.4

1.75

344

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

426

2758

1.59

17.21

4.9

3.6

1.8

1.7

mmol/l

0.24

331

2016

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4529

42806

1.44

17.10

5.7

5.0

2.6

2.7

mmol/l

13.10

4193

39413

(3020961) Endomysium IgA Ab [Titer] in Serum

300

1786

1.72

16.81

1.2

1.1

106.4

191.8

titre

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

451

2978

1.56

16.73

1.6

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

158

765

2.10

16.70

1.6

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

155

747

2.11

16.59

1.8

1.5

104.8

120.4

u/ml

0.93

144

(3000570) Elastase.pancreatic [Mass/mass] in Stool

225

1237

1.86

16.50

1.6

1.4

254.9

272.6

ug/g

0.66

144

723

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

340

2108

1.66

16.36

1.9

1.7

1.5

g/l

0.00

290

1816

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

132

607

2.21

15.92

1.6

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

166

838

2.01

15.69

1.8

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

167

846

2.01

15.64

4.2

3.6

57.5

57.9

0.12

167

846

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

388

2.50

15.54

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.74

15.37

2.1

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

196

1055

1.89

15.37

1.7

1.6

9528.2

12948.8

e6/l

0.78

153

758

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2869

25619

1.27

15.23

3.0

2.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

404

2.45

15.22

1.7

1.5

29.6

30.0

0.03

249

(3018677) aPTT in Platelet poor plasma by Coagulation assay

913

7028

1.36

14.96

2.4

2.1

30.0

0.02

885

6837

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

208

1154

1.84

14.84

1.4

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

135

3.58

14.73

3.1

3.9

6.8

7.9

mg/l

0.59

115

(3015235) Bicarbonate [Moles/volume] in Capillary blood

209

1165

1.83

14.69

4.2

3.3

25.3

24.7

mmol/l

1.04

188

1002

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

169

881

1.95

14.60

1.7

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

289

2.69

14.50

2.5

2.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

208

1165

1.82

14.40

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1134

9078

1.32

14.17

1.7

37785113.7

28184165.7

pmol/l

0.22

966

7554

(3011412) CD3 cells [#/volume] in Blood

394

2.41

14.11

2.4

1.1

1.2

e9/l

0.45

230

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

193

1064

1.85

14.07

2.0

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

208

1174

1.80

14.05

1.4

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

186

1017

1.86

13.92

1.4

1.2

4.0

7.6

u/ml

1.16

160

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

152

778

1.98

13.87

1.4

1.2

268.3

267.4

u/ml

0.01

485

(3042733) HLA Ab [Presence] in Serum

136

3.48

13.84

5.7

4.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

127

611

2.11

13.72

7.0

6.8

11.7

mg/l

0.01

120

566

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3103

28140

1.25

13.68

3.8

3.1

57.3

51.4

u/l

1.97

2893

26174

(3037692) Legionella sp identified in Specimen by Organism specific culture

147

3.36

13.65

1.8

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

159

832

1.94

13.61

1.4

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

183

1003

1.85

13.60

1.4

1.2

3.5

6.1

u/ml

0.29

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

114

3.71

13.59

2.1

1.4

9.5

8.8

ug/l

0.44

114

(3003327) Ova and parasites identified in Stool by Light microscopy

215

1239

1.77

13.55

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

263

1608

1.67

13.38

3.6

3.2

0.3

u/ml

0.37

164

911

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

135

3.43

13.27

2.8

2.1

61.7

60.6

ug/l

0.03

130

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.78

13.05

5.0

6.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

103

467

2.23

12.94

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

417

2.30

12.88

1.3

1.4

161687.7

93332.3

e6/l

0.29

298

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

405

2.32

12.85

2.1

1.6

—

(3023419) Bacteria identified in Sputum by Culture

112

527

2.15

12.84

2.4

2.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1271

10448

1.29

12.83

2.9

2.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

153

807

1.92

12.82

1.3

1.2

3.2

5.5

u/ml

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

172

947

1.84

12.63

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

190

1079

1.79

12.61

1.4

1.2

9.8

36.2

u/ml

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

110

528

2.11

12.00

1.7

1.6

57.3

60.4

0.31

332

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

107

509

2.13

11.95

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

132

681

1.96

11.83

1.5

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

120

599

2.03

11.80

1.5

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

353

2.34

11.67

2.0

2.2

37.3

43.3

—

(3002385) Erythrocyte distribution width [Ratio]

3760

35118

1.25

11.56

24.4

17.9

13.9

13.7

13.51

3696

34353

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

319

2.40

11.45

2.1

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

331

2225

1.52

11.31

5.3

4.1

23.9

24.1

mmol/l

0.77

265

2015

(3004716) Salmonella sp identified in Stool by Organism specific culture

290

1901

1.56

11.11

1.5

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

188

1119

1.71

10.64

2.0

1.9

11.5

11.2

mg/l

0.15

175

1033

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

192

1152

1.69

10.55

2.5

2.3

203.2

121.7

ug/min

0.82

117

706

(3001964) Herpes simplex virus Ag [Presence] in Specimen

121

3.24

10.38

1.7

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

304

2.35

10.27

2.3

2.1

14.5

13.6

0.16

132

(3048929) Epstein Barr virus Ab [Presence] in Serum

197

1199

1.67

10.27

1.4

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

274

1806

1.55

10.26

2.1

1.9

39.1

38.7

u/l

0.11

242

1585

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

359

2509

1.46

10.14

8.4

10.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

196

1197

1.66

10.09

1.4

13.3

18.0

iu/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

177

2.79

10.04

1.2

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

1580

13638

1.23

9.95

3.0

2.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

180

1082

1.69

9.85

4.3

3.1

8.2

kpa

0.22

170

993

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

815

6523

1.30

9.84

1.5

—

(3003338) MCHC [Mass/volume]

3819

35944

1.23

9.83

29.6

18.8

332.1

332.9

g/l

5.81

3791

35663

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

193

1188

1.65

9.65

5.3

3.4

1.7

1.5

mg/l

1.45

180

1093

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

138

777

1.80

9.52

1.4

1.2

54.3

41.2

u/ml

0.48

(40757373) Influenza virus identified in Isolate

3.46

9.45

1.8

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

338

2378

1.45

9.23

3.2

3.3

4.4

4.5

pmol/l

1.22

288

2098

(3008757) Leukocyte morphology finding [Identifier] in Blood

479

2.00

9.18

4.8

4.0

—

(3021901) Oxygen saturation in Capillary blood

145

842

1.74

9.02

3.6

2.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

386

2799

1.41

8.94

2.4

36.4

23.5

au/ml

1.04

133

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

208

1331

1.59

8.91

2.0

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

105

557

1.90

8.78

1.4

—

(3037756) Immunofixation for Serum or Plasma

157

941

1.69

8.73

1.5

1.7

—

(3026782) Osmolality of Urine

1039

8687

1.24

8.63

3.6

2.8

527.2

557.8

mosm/kgh2o

5.08

927

7399

(3000093) Morphology [Interpretation] in Blood Narrative

435

2.02

8.63

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

204

2.51

8.61

5.5

3.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

142

2.83

8.51

1.5

1.3

61.3

55.3

0.47

122

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

159

963

1.67

8.51

1.7

1.5

—

(3022313) Gas panel - Capillary blood

299

2090

1.46

8.47

5.2

3.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

134

778

1.74

8.37

1.5

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

201

1296

1.57

8.35

2.6

2.8

3.5

3.6

g/l

0.10

187

1234

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

341

2449

1.42

8.35

7.3

9.7

24.2

mmol/l

0.05

304

2296

(3035947) Staphylolysin Ab [Units/volume] in Serum

220

2.42

8.29

1.3

1.1

4.7

3.9

iu/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

276

2.26

8.28

2.6

2.5

512.9

527.0

e6/l

0.08

229

(3004809) Band form neutrophils/100 leukocytes in Blood

130

751

1.75

8.27

4.5

3.4

1.1

1.7

1.33

103

569

(3022145) Colonoscopy Study observation

604

4754

1.31

8.20

1.4

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

134

2.85

8.20

1.9

2.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

204

2.47

8.12

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

393

2913

1.38

8.00

3.6

3.0

4.3

4.1

e9/l

0.43

293

2270

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

115

649

1.79

7.94

1.2

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

248

1693

1.49

7.94

2.0

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4192

40101

1.23

7.92

18.4

13.9

79.1

80.2

ml/min/173m2

2.21

3580

33224

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

101

549

1.86

7.88

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

159

984

1.64

7.85

2.6

2.8

31.7

35.1

umol/l

1.10

135

836

(3037121) Protein [Mass/volume] in Urine

226

1523

1.51

7.71

4.5

3.1

0.2

0.3

g/l

1.19

117

657

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

405

1.99

7.71

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

101

553

1.84

7.71

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

387

2882

1.37

7.66

1.8

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

134

2.77

7.62

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

157

977

1.63

7.60

1.6

1.5

—

(3024471) HLA-A [Type]

140

2.73

7.59

1.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

577

4562

1.30

7.57

4.2

3.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

347

2546

1.39

7.52

1.3

64.5

54.1

au/ml

0.24

117

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

423

1.95

7.50

2.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

545

1.83

7.44

1.4

—

(3024932) HLA-DR beta [Type]

137

2.71

7.33

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

267

2.19

7.20

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

248

2.23

7.18

1.6

1.4

5.8

6.9

u/l

0.57

212

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1017

8635

1.22

7.17

4.7

3.8

345.3

562.1

ng/l

0.98

795

6917

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

642

5181

1.27

7.16

2.1

1.8

1.6

1.5

1.40

553

4545

(3013139) Helicobacter pylori Ag [Presence] in Stool

357

2657

1.37

7.10

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

128

2.75

7.10

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

613

4926

1.28

7.07

3.4

2.8

9.3

8.8

umol/l

0.21

530

4323

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

547

1.81

7.06

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

549

1.80

6.98

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

110

638

1.74

6.97

4.8

5.0

347.3

359.0

umol/l

0.36

552

(3016650) Hepatitis A virus Ab [Presence] in Serum

116

684

1.71

6.93

1.1

—

(44813793)

252

2.20

6.92

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

429

1.90

6.89

1.2

68.9

63.7

u/l

0.17

281

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

246

2.21

6.89

1.4

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

272

1944

1.42

6.89

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

261

1852

1.43

6.88

2.3

1.9

—

(3003181) Sodium [Moles/volume] in Urine

128

777

1.66

6.87

1.3

62.9

63.6

mmol/l

0.06

100

628

(21494755) Public health laboratory ask at order entry panel

266

3675

0.71

6.86

1.3

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

114

675

1.70

6.72

1.6

0.7

0.9

g/l

1.35

515

(3047181) Lactate [Moles/volume] in Blood

208

1421

1.48

6.69

6.2

6.3

1.4

1.3

mmol/l

0.73

183

1257

(3028433) Virus identified in Specimen by Culture

133

2.64

6.63

1.3

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

370

2802

1.34

6.60

7.3

7.4

24.8

mmol/l

0.02

365

2785

(40768797) Stomach Pathology biopsy report

709

5845

1.25

6.57

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

145

919

1.59

6.57

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

145

919

1.59

6.57

1.4

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

245

2.18

6.55

1.4

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

254

1811

1.42

6.53

5.5

3.8

24.8

mmol/l

0.00

237

1671

(1616796) Gas panel - Central venous blood

156

1008

1.56

6.51

5.0

3.9

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

4.56

6.45

1.8

2.0

1.7

mg/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2004

18196

1.16

6.43

4.6

5.0

3.2

3.4

ug/l

0.13

1796

16366

(3004616) Nuclear Ab [Presence] in Serum

493

1.80

6.31

1.4

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

125

2.65

6.30

1.7

2.0

7.9

8.7

mg/l

0.45

105

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.84

6.25

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

168

2.39

6.19

2.5

2.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

231

1641

1.43

6.09

2.4

2.3

3.1

g/l

0.10

173

1277

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

147

953

1.56

6.07

2.5

2.2

1567.4

4160.2

u/l

1.37

365

(3042631) Mycobacterium sp identified in Specimen

103

614

1.69

5.97

2.4

2.6

—

(3044941) Cell count panel - Synovial fluid

113

692

1.65

5.92

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

403

3142

1.31

5.88

1.2

—

(40768446) Kidney Pathology biopsy report

166

2.36

5.87

2.2

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

264

2.06

5.82

1.7

1.6

6.4

6.5

u/l

0.01

121

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.18

5.81

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

205

2.21

5.80

1.6

1.4

0.9

3.9

1.85

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

138

2.47

5.68

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

151

1003

1.52

5.62

2.9

2.2

129.3

130.2

g/l

0.15

110

721

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

177

1218

1.47

5.55

1.4

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

345

2656

1.32

5.53

1.9

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

426

1.80

5.49

1.2

1.3

1.4

1.5

nmol/l

0.17

378

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1616

14568

1.16

5.49

4.4

4.3

22.8

21.9

1.35

801

7148

(21494814) CD8 cells/100 lymphocytes in Specimen

166

2.30

5.43

1.8

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

436

1.78

5.39

2.8

3.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

497

1.72

5.33

1.8

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

141

938

1.52

5.24

2.4

1.9

0.8

nmol/l

0.13

122

783

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

477

3862

1.26

5.18

3.4

2.9

213.9

205.7

ng/l

0.17

442

3505

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

176

2.23

5.18

2.4

1.8

157.7

143.6

umol/l

0.11

101

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

200

1428

1.42

5.18

3.2

3.4

37.6

59.4

mg/l

1.28

160

1162

(3003434) Protein [Mass/volume] in Pleural fluid

104

647

1.62

5.17

1.4

1.5

31.5

32.7

g/l

0.40

582

(3034860) Kappa light chains.free [Mass/volume] in Serum

200

1429

1.42

5.16

3.2

3.4

43.0

98.9

mg/l

0.79

162

1159

(3028192) IgG subclass 2 [Mass/volume] in Serum

420

1.77

5.16

1.6

1.4

3.2

2.9

g/l

0.68

295

(3024139) IgG subclass 3 [Mass/volume] in Serum

420

1.77

5.16

1.6

1.4

0.5

0.4

g/l

0.98

294

(3027135) IgG subclass 1 [Mass/volume] in Serum

420

1.77

5.16

1.6

1.4

6.5

6.8

g/l

0.27

296

(3021788) Differential panel - Synovial fluid

122

789

1.56

5.16

1.7

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.80

5.13

1.1

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

196

1397

1.42

5.13

3.2

3.3

1.6

2.7

ratio

0.90

114

(4062490)

422

1.76

5.08

1.6

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

128

2.43

5.03

1.1

1.6

15.0

15.5

pmol/l

0.21

110

(3030981) Hyaline casts [#/volume] in Urine by Automated count

307

2359

1.32

5.02

2.8

0.4

0.3

e6/l

0.31

300

2303

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

190

1353

1.42

5.00

2.4

2.1

37.3

37.7

g/l

0.45

165

1162

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

260

1.97

4.96

1.2

1.3

0.5

0.7

u/ml

0.12

122

(4034850)

192

1373

1.41

4.94

12.9

9.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

237

1757

1.37

4.92

2.4

2.3

3.8

g/l

0.36

173

1247

(3002619) Bacteria identified in Specimen by Culture

2.87

4.91

1.6

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

237

1758

1.36

4.91

2.4

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

237

1759

1.36

4.89

2.4

2.3

7.5

7.4

g/l

0.30

177

1302

(3017354) Segmented neutrophils/100 leukocytes in Blood

472

1.71

4.89

4.2

3.5

61.3

57.7

0.91

292

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

437

1.73

4.80

1.5

1.4

23.8

26.8

u/l

0.38

359

(40765096) Chromosome analysis panel by Banding

144

2.30

4.76

1.3

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

171

1207

1.43

4.75

2.6

2.2

0.0

g/l

0.00

156

1101

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

244

1.98

4.72

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

577

1.62

4.71

1.5

1.4

1847.2

1998.7

e6/l

0.09

419

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

177

2.16

4.70

2.1

2.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

153

1061

1.46

4.67

1.4

525.8

537.2

mg/l

0.08

147

999

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

382

1.76

4.64

1.7

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.58

4.63

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

168

1191

1.42

4.57

2.6

2.2

0.0

g/l

0.00

155

1100

(3034770) Mitochondria Ab [Titer] in Serum

165

1166

1.43

4.57

1.2

1721.3

926.4

titre

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

290

2242

1.31

4.56

2.5

2.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

181

1302

1.40

4.54

2.5

2.2

0.0

g/l

1.04

166

1192

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

437

1.70

4.54

1.1

—

3.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

203

1489

1.38

4.53

2.6

2.4

0.7

1.0

g/l

0.71

177

1275

(21494890) Protein electrophoresis panel - 24 hour Urine

475

1.67

4.53

2.4

2.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

2.72

4.50

1.1

1.8

1.5

2.1

ug/l

0.80

(3013512) EKG study

1401

12652

1.15

4.48

4.5

4.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

533

4440

1.22

4.48

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

219

1633

1.36

4.42

2.4

2.3

10.1

10.2

g/l

0.18

177

1377

(3039000) Anion gap in Blood

147

1024

1.45

4.41

7.1

7.2

11.5

11.3

mmol/l

0.23

132

921

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

248

1886

1.33

4.39

5.4

5.2

1.8

1.7

0.78

232

1768

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

136

934

1.47

4.39

1.4

1.3

3.7

3.8

mmol/l

0.95

126

872

(3018572) Chloride [Moles/volume] in Blood

147

1025

1.45

4.39

7.1

7.2

105.1

mmol/l

0.08

132

922

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

183

1328

1.39

4.37

2.5

90.6

89.9

0.14

173

1256

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

176

2.11

4.37

2.1

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

176

2.11

4.37

2.1

2.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

519

1.63

4.35

1.4

67172.5

70924.2

e6/l

0.04

306

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

157

2.17

4.32

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

278

3554

0.77

4.32

1.7

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

163

1166

1.41

4.24

1.2

104.2

91.5

titre

0.33

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.14

4.20

1.2

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

179

2.07

4.20

1.7

1.5

29.8

29.0

umol/l

0.23

172

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1254

11285

1.15

4.18

1.9

1.6

1.4

mmol/l

1.74

1073

9482

(1761868) Lipid panel - Serum or Plasma

1342

14782

0.88

4.17

3.0

2.9

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

4.08

4.16

1.2

1.0

—

(3045788) Cell count panel - Pleural fluid

449

1.66

4.14

1.4

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

187

2.04

4.13

2.4

5.8

59.1

70.9

mg/l

0.77

131

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

149

1055

1.42

4.12

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

559

1.58

4.10

1.5

1.4

48.3

59.2

mu/l

0.35

497

(3041096) Erythrocytes [Presence] in Urine by Automated

1232

11088

1.15

4.09

4.4

3.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

431

3546

1.23

4.09

4.9

4.0

1.2

mmol/l

0.03

392

3124

(3035637) Corticotropin [Mass/volume] in Plasma

521

1.60

4.06

1.7

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

472

3930

1.22

4.00

2.3

2.2

13.2

12.9

nmol/l

0.28

423

3469

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.44

3.98

2.4

2.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.82

3.95

1.5

1.2

40.0

62.7

ng/l

—

(3008898) HLA-B27 [Presence]

174

1277

1.38

3.92

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

164

2.08

3.91

1.3

1.1

1648.9

1550.5

miu/ml

0.19

164

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

144

1024

1.42

3.91

1.3

157.9

206.4

miu/ml

0.86

443

(40760888) Immunoglobulin light chains.free panel - Serum

151

1085

1.40

3.87

3.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

7.28

3.85

4.3

5.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

451

1.63

3.83

1.4

1.3

391.4

345.0

u/l

0.24

433

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

338

1.72

3.79

1.5

1.3

3.1

2.0

mmol/l

0.95

318

(3009542) Hematocrit [Volume Fraction] of Blood

3993

38682

1.14

3.76

21.0

15.7

39.7

39.9

0.95

2533

27448

(3008295) Osmolality of Serum or Plasma

469

1.61

3.76

1.5

1.4

281.7

280.3

mosm/kgh2o

0.19

361

(40767503) Oxygen content in Capillary blood by calculation

139

991

1.41

3.73

3.8

2.5

16.3

0.10

499

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

121

2.24

3.73

1.1

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.64

3.72

1.2

1.8

104.1

147.1

ng/l

0.87

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

621

1.52

3.72

1.2

1.9

4.0

u/ml

1.72

210

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

289

1.77

3.68

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

289

1.77

3.68

1.3

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

239

1859

1.30

3.66

5.5

5.3

0.9

0.09

224

1746

(3019225) pH of Specimen

513

4347

1.20

3.64

5.6

4.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

290

1.77

3.64

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

291

1.76

3.60

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

291

1.76

3.60

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

515

1.56

3.57

1.3

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

198

1.93

3.57

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

539

1.55

3.56

2.6

2.1

26.3

22.7

mg/l

0.31

133

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

292

1.75

3.56

1.3

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

270

1.78

3.56

1.1

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

388

3208

1.23

3.55

2.0

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

173

1291

1.35

3.55

3.7

3.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

143

1035

1.39

3.54

1.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

227

1.86

3.54

2.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

227

1.86

3.54

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

227

1.86

3.54

2.0

1.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

213

1.88

3.52

1.1

89.3

89.2

u/l

0.00

165

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

164

1215

1.36

3.52

3.3

2.7

215.7

193.7

1.79

155

1161

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

271

1.78

3.52

1.1

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

103

703

1.47

3.51

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

214

1.88

3.48

1.1

29.8

30.0

u/l

0.01

160

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

112

2.24

3.47

1.3

29.4

30.5

0.05

(3035880) pH of Pleural fluid

265

1.78

3.47

1.4

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

1229

11174

1.13

3.43

5.2

4.1

87.9

0.04

1203

10923

(3014271) Vancomycin [Susceptibility]

223

1.85

3.40

3.7

2.9

—

(3032057) Clostridioides difficile [Presence] in Stool

2.39

3.38

2.0

—

(3002256) Pathology report gross observation

642

5589

1.17

3.34

1.4

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

605

1.50

3.32

1.2

3.4

4.8

u/ml

0.97

257

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.62

3.30

1.2

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

345

1.66

3.29

2.1

1.9

14.7

8.6

umol/l

0.38

238

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

233

1.81

3.28

1.9

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

233

1.81

3.28

1.9

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

285

1.73

3.27

1.1

—

(21494434) Karyotype in Bone marrow

401

1.60

3.23

1.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

227

1.81

3.23

2.0

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

185

1422

1.31

3.14

1.9

2.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

165

1.95

3.13

1.1

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.54

3.12

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

563

4880

1.17

3.10

1.5

1.4

—

(3024263) Appearance of Synovial fluid

239

1.76

3.04

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

528

1.50

3.03

1.4

1.3

300.9

273.6

pmol/l

0.24

408

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

354

1.62

3.01

1.4

1.3

12.6

13.4

u/l

0.14

326

(3040151) Glucose [Moles/volume] in Capillary blood

513

1.51

3.00

5.3

19.2

8.2

7.4

mmol/l

0.77

432

(3012441) Differential panel - Pleural fluid

506

1.51

2.97

1.3

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

458

1.54

2.97

1.4

6.2

6.4

mmol/l

0.27

426

(3009214) Lutropin [Units/volume] in Serum or Plasma

148

1112

1.34

2.96

1.6

1.4

9.7

8.9

u/l

0.35

124

893

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

280

1.68

2.92

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

228

1.76

2.90

1.1

1.2

1.1

1.0

ratio

0.58

(3027315) Oxygen [Partial pressure] in Blood

140

1047

1.35

2.90

6.0

4.7

8.5

kpa

0.16

135

1030

(3010421) pH of Blood

159

1212

1.32

2.89

5.6

4.5

7.4

0.53

133

1026

(3001019) Free T4 and TSH panel - Serum or Plasma

138

1829

0.75

2.89

1.5

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.70

2.88

1.6

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

126

928

1.37

2.88

1.5

1.4

28.0

22.1

e6/l

0.09

102

714

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

126

928

1.37

2.88

1.6

1.5

1213.4

1264.2

e6/l

0.02

108

755

(3013290) Carbon dioxide [Partial pressure] in Blood

139

1041

1.34

2.85

6.0

4.6

5.1

5.0

kpa

0.36

134

1025

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

171

1.88

2.85

2.2

583.6

201.6

ug/l

0.29

157

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

222

1.76

2.84

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

116

2.07

2.82

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

140

1052

1.34

2.82

1.1

3.4

6.6

u/ml

1.12

123

(3017704) Immunofixation for Urine

253

1.71

2.80

1.7

1.6

—

(3036489) Thrombin time

204

1618

1.27

2.77

2.5

2.3

21.5

21.7

0.16

184

1438

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

117

2.06

2.76

1.1

91.8

86.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

217

1.76

2.75

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

111

808

1.38

2.74

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.20

2.73

1.0

1.1

—

(3012501) Base excess in Blood by calculation

138

1041

1.33

2.72

6.0

4.6

2.5

2.6

mmol/l

0.10

100

712

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

141

1068

1.33

2.70

2.0

1.9

189.5

205.2

pmol/l

1.10

135

1007

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

204

1.77

2.68

2.3

2.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

711

1.40

2.66

1.1

82.7

847.0

iu/ml

0.50

164

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

119

2.02

2.65

1.2

—

(3000492) Spirometry study

469

4061

1.17

2.64

1.6

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

468

4057

1.17

2.60

2.9

2.5

32.7

51.2

u/l

0.92

408

3485

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

275

1.64

2.58

1.4

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

7.15

2.55

1.0

1.1

1.4

1.2

mg/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.73

2.54

2.4

1.5

47.0

43.7

umol/l

0.16

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

220

1784

1.24

2.50

2.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

115

2.00

2.50

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

356

1.55

2.50

1.5

—

(44806071)

2.67

2.45

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.55

2.44

1.1

1.0

—

(3045716) Anion gap in Serum or Plasma

219

1.69

2.40

2.1

2.4

8.9

9.3

mmol/l

0.26

170

(3003129) Base excess in Capillary blood by calculation

117

1.97

2.40

1.7

2.0

0.4

1.0

mmol/l

0.24

108

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

117

1.97

2.40

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

117

1.97

2.40

1.1

1.3

101.3

81.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

220

1.69

2.37

1.1

u/l

0.46

120

(3008536) Aspergillus sp Ab [Presence] in Serum

2.21

2.37

1.3

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

785

7101

1.12

2.36

3.6

3.0

2.1

2.0

e6/l

0.14

483

3895

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

1.86

2.31

2.8

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

1.86

2.31

2.8

2.4

—

(3019977) pH of Arterial blood

268

1.61

2.31

2.6

2.5

7.4

0.16

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

184

1478

1.25

2.30

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

105

2.00

2.30

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.48

2.27

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

188

2315

0.81

2.26

1.4

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

127

1.89

2.25

1.5

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

127

1.89

2.25

2.4

2.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

120

1.92

2.25

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

120

1.92

2.25

1.4

30.3

22.6

0.52

(3024891) Influenza virus A+B Ag [Presence] in Specimen

139

1084

1.29

2.22

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

102

762

1.35

2.21

1.2

1.3

30.2

42.8

u/l

0.90

660

(3045414) Leukocytes [Presence] in Urine

235

1949

1.22

2.20

2.2

1.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.50

2.18

1.8

2.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

226

1.64

2.17

4.2

3.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

730

1.35

2.17

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

512

1.41

2.11

1.4

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

1.87

2.11

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.45

2.10

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.00

2.10

1.7

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.08

2.06

1.1

1.2

117.5

77.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

111

851

1.31

2.04

3.7

3.0

0.8

nmol/l

0.10

641

(3042951) Complement C1q Ab [Units/volume] in Serum

4.00

2.04

1.0

1.1

—

26.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

294

1.54

2.02

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.40

2.02

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

527

1.39

1.98

1.4

1.3

—

(3049717) Cytology report of Urine Cyto stain

220

1834

1.21

1.98

2.2

2.7

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

570

1.37

1.97

2.3

32.5

32.6

0.13

565

(3009015) Lactate [Moles/volume] in Synovial fluid

2.36

1.94

1.2

8.6

5.7

mmol/l

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

179

1.68

1.94

3.3

1.8

150.1

158.8

0.13

170

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.55

1.94

3.2

3.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.55

1.94

3.2

2.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.73

1.93

1.3

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.57

1.92

1.3

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

347

1.47

1.91

1.4

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

165

1.70

1.90

1.1

161.1

341.2

ng/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

243

1.57

1.89

2.0

—

(4035726)

431

3812

1.14

1.89

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

204

1.62

1.88

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

204

1.62

1.88

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.16

1.87

10.6

12.0

5.7

6.2

mmol/l

0.13

(40761536) Microorganisms panel - Urine sediment

404

3560

1.15

1.87

5.5

3.9

—

(4306422)

602

1.35

1.86

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

403

3553

1.15

1.85

2.1

2.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.39

1.85

1.2

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

293

1.51

1.84

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

375

1.44

1.84

1.0

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

3.53

1.83

1.7

1.0

11.1

0.8

u/ml

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

253

1.55

1.83

1.5

—

(3044927) Protein electrophoresis panel - Urine

459

1.40

1.83

1.4

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

115

1.83

1.82

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

4.17

1.82

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

283

2434

1.17

1.82

1.2

137.1

144.8

iu/ml

0.12

114

879

(4015189)

108

1.86

1.81

1.5

1.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

109

1.84

1.77

1.5

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.34

1.74

1.0

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.98

1.74

1.1

1.2

92.8

78.0

—

(3042517) Benzodiazepines panel - Urine

2.67

1.72

1.9

2.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

102

796

1.29

1.70

1.4

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

324

1.45

1.68

1.3

10.5

12.1

mmol/l

0.97

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.86

1.65

1.0

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

384

1.41

1.65

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

747

1.29

1.64

5.3

3.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.98

1.64

1.5

1.2

3.3

1.7

mmol/l

—

(3044290) Cell count panel - Cerebral spinal fluid

108

854

1.27

1.63

1.7

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

253

1.51

1.62

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

229

1.53

1.62

9.7

5.9

45.0

800.6

u/ml

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

221

1.54

1.61

1.4

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

270

1.49

1.60

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

463

1.37

1.60

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

148

1218

1.22

1.58

1.7

1.6

276.6

297.7

mu/l

0.39

139

1110

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.00

1.58

1.0

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

587

1.32

1.55

1.4

1.3

0.3

nmol/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.11

1.55

1.1

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

289

1.46

1.54

2.2

2.0

4.2

3.5

ug/l

0.19

250

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

570

1.32

1.54

1.1

120.1

114.1

0.90

518

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

166

1386

1.20

1.54

1.7

1.8

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.43

1.53

2.4

2.8

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

306

1.44

1.53

1.1

281.3

301.7

mg/l

0.30

260

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.34

1.52

1.0

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

242

1.49

1.3

1.2

nmol/l

0.26

188

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

574

1.31

1.48

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

124

1.70

1.46

1.4

1.9

15.8

56.9

u/l

1.35

117

(3004451) EKG impression Narrative

219

1.51

1.45

1.5

1.2

—

(4268621)

420

1.36

1.45

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

127

1040

1.23

1.45

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.04

1.43

1.1

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

188

1.55

1.42

1.2

1.5

50.6

65.8

1.13

155

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

245

1.47

1.42

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

149

1.61

1.40

3.5

2.8

30.3

29.7

umol/l

0.12

106

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

580

1.30

1.39

1.7

2.0

15.4

25.2

ug/l

3.29

572

(3052592) Norovirus Ag [Presence] in Stool

1.89

1.38

1.1

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

230

1.48

1.38

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

599

1.29

1.37

1.2

1.1

—

(3000012) Reticulocyte production index

223

1.48

1.35

1.3

1.5

—

(40768441) Liver Pathology biopsy report

298

1.41

1.35

1.3

1.4

—

(4027681)

240

1.46

1.34

1.2

—

(3025577) Chromium [Mass/volume] in Blood

282

1.42

1.33

2.2

2.1

2.2

2.1

ug/l

0.06

240

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

453

1.33

1.6

1.4

0.2

0.3

nmol/l

0.97

345

(3036048) Francisella tularensis Ab [Titer] in Serum

105

1.72

1.33

1.2

—

184.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

360

1.36

1.29

2.0

1.3

1.4

1.2

promille

0.18

276

(3025549) Creatine [Moles/time] in 24 hour Urine

2.35

1.29

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

430

1.33

1.28

3.2

3.0

83.3

43.8

mg/l

0.43

329

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

114

938

1.22

1.27

1.9

1.8

3.6

4.6

iu/l

0.98

320

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.09

1.27

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

544

1.29

1.27

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

146

1.58

1.25

6.5

3.3

53.0

55.2

0.17

141

(3024928) Oxygen saturation in Venous blood

118

977

1.21

1.25

3.6

3.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.40

1.24

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

131

1.61

1.23

1.3

1.2

36.9

40.0

g/l

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

304

1.38

1.23

1.3

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.72

1.21

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

263

0.61

1.19

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

141

1.56

1.17

1.3

1.2

53.6

372.8

ug/l

0.95

(40768800) Prostate Pathology biopsy report

1135

0.82

1.16

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

316

1.36

1.16

1.2

34.8

45.5

mg/l

1.68

256

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

1.16

0.0

1.8

—

21.1

—

(3051611) Lipemic interference index of Serum or Plasma

438

1.30

1.15

3.8

3.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.50

1.15

15.0

10.8

—

(3010937) Rubella virus Ab [Presence] in Serum

2.50

1.15

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

110

1.64

1.15

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

110

1.64

1.15

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

110

1.64

1.15

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

110

1.64

1.15

1.1

1.0

—

(3022621) pH of Urine by Test strip

313

2815

1.12

1.14

3.3

2.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

216

1.44

1.13

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

331

0.66

1.13

1.0

784.7

724.8

ng/l

0.34

224

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

103

1.65

1.12

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.34

1.12

1.4

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.67

1.10

1.1

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.82

1.08

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.82

1.08

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.82

1.08

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

540

1.26

1.08

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

304

1.35

1.06

2.4

—

(3016018) Differential panel - Cerebral spinal fluid

445

1.28

1.04

1.8

1.5

—

(3017569) Oxygen content in Arterial blood

237

1.39

1.04

2.0

2.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.27

1.03

1.0

1.2

—

(4212803)

1.96

1.03

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

420

1.29

1.02

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

155

1.49

1.00

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

448

1.28

1.00

3.1

3.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.88

1.00

1.6

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

333

0.69

0.99

1.0

33.4

44.4

ng/l

1.18

224

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

489

4536

1.09

0.98

3.4

4.2

19.8

19.6

ug/l

0.01

396

3738

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

332

0.69

0.98

1.0

229.6

311.6

ng/l

2.28

229

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.80

0.98

1.1

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

521

1.25

0.98

1.4

1.3

—

nmol/l

—

(3016038) Potassium [Moles/volume] in Urine

292

1.34

0.97

1.1

1.2

32.2

35.1

mmol/l

0.37

255

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

292

1.34

0.97

1.5

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

249

1.37

0.97

1.1

5.1

10.4

iu/ml

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.63

0.97

2.7

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.80

0.96

1.6

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

124

1.53

0.96

3.3

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.69

0.95

3.6

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.94

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.78

0.94

1.3

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

101

1.59

0.93

1.1

1.5

0.4

ug/l

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

347

1.30

0.93

1.2

226.7

153.2

titre

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.14

0.91

1.0

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

564

5286

1.08

0.89

4.7

4.6

31.6

32.2

0.51

392

3580

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.91

0.88

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1204

11567

1.05

0.86

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

212

1.37

0.86

2.1

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

1.54

0.84

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.78

0.84

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

191

0.63

0.84

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

633

1.20

0.83

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

202

0.64

0.82

1.1

1.4

—

(4094501)

108

1251

0.86

0.82

1.1

—

(3051651) Icteric interference index of Serum or Plasma

266

1.32

0.82

3.6

3.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.69

0.82

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

736

1.19

0.81

1.5

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.79

0.0

1.0

—

94.3

—

(3025315) Body weight

1.82

0.79

5.8

3.9

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.2

—

(3014891) Appearance of Pleural fluid

1.67

0.78

1.7

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

123

1.47

0.77

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

217

1.34

0.76

2.1

1.6

1.1

3.2

u/field

1.41

154

(3013293) Extractable nuclear Ab [Presence] in Serum

1.70

0.75

1.9

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

559

1.20

0.74

1.2

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.08

0.74

1.0

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.67

0.74

1.2

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

141

1.42

0.74

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

117

1025

1.14

0.73

1.5

1.4

—

(3011648) Oxygen content in Venous blood

370

1.25

0.72

3.2

2.9

11.8

11.2

0.52

370

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

282

1.28

0.70

1.6

1.4

2.4

4.4

ug/l

1.26

244

(3023511) Choriogonadotropin [Units/volume] in Urine

472

1.21

0.70

1.3

—

(3001729) Color of Synovial fluid

1.71

0.70

2.7

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

152

1.38

0.69

2.1

1.9

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.53

0.68

3.7

3.1

85.7

83.4

u/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.85

0.68

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.79

0.66

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

107

941

1.14

0.65

4.5

3.4

33.5

27.8

mg/l

0.66

589

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.59

0.65

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

471

0.81

0.64

1.6

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

120

1.42

0.64

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

350

1.23

0.63

3.3

5.1

238.9

62.3

u/ml

—

(3048879) Bone marrow aspiration report

129

1.40

0.63

1.2

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

107

945

1.14

0.62

2.7

3.6

436.5

802.5

u/ml

0.40

867

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.51

0.58

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

255

1.26

0.58

1.2

1.1

15.5

7.0

nmol/l

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.46

0.56

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.56

0.55

8.4

7.9

—

(40768793) Breast Pathology biopsy report

763

0.86

0.55

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

461

0.82

0.55

1.5

1.4

—

(3005033) Fetal Nuchal fold Thickness US

459

0.83

0.53

1.5

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.54

0.53

2.5

2.4

0.5

0.7

u/field

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

723

1.14

0.52

1.8

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.47

0.50

1.6

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

584

1.15

0.50

3.3

3.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

390

1.18

0.49

1.3

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1021

10513

0.96

0.49

2.8

3.0

0.7

0.8

ug/l

0.33

677

7055

(3028717) Thiamine [Mass/volume] in Blood

1.52

0.48

1.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.40

0.48

1.1

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.40

0.48

2.0

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

1.41

0.46

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

384

1.17

0.45

2.0

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

675

1.13

0.45

1.5

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.40

0.45

1.7

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.40

0.45

1.1

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

110

1000

1.10

0.44

2.5

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

113

1030

1.10

0.43

2.5

2.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

104

1.35

0.43

1.9

2.9

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.61

0.43

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

1.61

0.43

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.43

0.42

2.6

1.5

0.2

0.1

nmol/l

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.56

0.42

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.40

0.42

1.5

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

552

0.87

0.41

2.9

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

360

1.17

0.41

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.52

0.41

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

4.8

—

3.5

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.41

0.0

1.1

—

11.1

—

(3001556) Androgen free Index in Serum or Plasma

1.47

0.40

1.2

—

(40758358) Immune stain study

0.00

0.40

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.36

0.40

1.6

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.34

0.39

1.5

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.43

0.39

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.39

1.2

1.1

—

(4146454)

484

1.14

0.39

3.1

2.7

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.5

—

1.9

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.39

0.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

106

0.66

0.39

2.7

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

106

0.66

0.39

5.4

6.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

611

0.88

0.38

1.4

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.35

0.37

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

116

1.29

0.37

1.2

1.1

—

(3016750) Collection duration of Urine

273

1.17

0.35

3.0

2.0

516.6

489.0

min

1.14

200

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

190

1.21

0.34

1.1

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

136

1.25

0.33

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

483

1.12

0.32

1.6

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

101

1.29

0.31

2.1

2.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

401

0.87

0.31

1.0

2.3

0.4

u/ml

—

109

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

177

1672

1.06

0.31

3.4

119.3

65.7

u/ml

0.30

170

1609

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

618

1.10

0.31

1.5

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

147

1382

1.07

0.30

1.5

1.4

21.7

28.7

iu/l

2.24

121

1153

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

120

1.25

0.30

2.4

6.6

72.8

71.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

130

0.77

0.29

1.6

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

147

1385

1.06

0.29

1.7

1.8

3.8

3.9

mg/l

0.06

114

975

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.32

0.28

1.3

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.25

0.27

1.8

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

433

1.11

0.26

1.0

1.1

7.4

4.2

u/ml

0.36

186

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

150

1.20

0.26

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.25

0.25

1.9

1.4

—

(3006270) Folate [Moles/volume] in Blood

378

1.11

0.24

1.2

372.0

357.7

nmol/l

0.14

321

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

191

0.84

0.24

1.3

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.28

0.24

1.1

1.3

—

95.5

titre

—

(1761482) Bacteria [#/volume] in Urine by Culture

104

1105

0.94

0.23

4.8

4.2

—

(3041354) Potassium [Moles/volume] in Venous blood

568

0.91

0.23

2.8

2.3

4.1

mmol/l

0.20

559

(3035285) Chloride [Moles/volume] in Venous blood

568

0.91

0.23

2.8

2.3

105.0

105.6

mmol/l

0.37

559

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

524

1.09

0.23

1.1

2.7

2.8

u/ml

0.07

223

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

556

0.92

0.22

3.4

3.7

34.5

32.8

u/ml

0.04

539

(3039443) Prostate specific Ag panel - Serum or Plasma

1019

0.94

0.22

1.4

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.19

0.21

1.6

2.6

—

(3050794) Legionella sp Ab [Presence] in Serum

1.19

0.21

1.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

0.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

239

1.13

0.21

4.6

6.6

—

(3011288) Drugs identified in Urine by Screen method

886

1.06

0.21

3.1

3.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

325

1.11

0.21

1.8

1.5

1.0

g/l

0.06

325

(4281824)

397

0.91

0.20

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.20

0.0

1.0

—

2.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.1

—

(3006462) Nitrate [Presence] in Urine

208

0.86

0.20

3.9

3.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

260

0.88

0.19

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

139

1330

1.05

0.19

2.3

2.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.19

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

137

1.17

0.18

1.3

1.1

—

(3034426) Prothrombin time (PT)

156

1.15

0.18

1.1

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

138

1323

1.04

0.18

2.3

2.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

559

0.93

0.18

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.21

0.17

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

558

0.93

0.17

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

247

0.89

0.17

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

167

1.14

0.16

2.2

1.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

557

0.93

0.16

1.4

—

(3028300) Cannabinoids [Presence] in Urine

139

1336

1.04

0.16

2.3

2.2

—

(3044007) Cell count panel - Peritoneal fluid

139

1.15

0.16

1.8

2.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

204

0.88

0.16

1.2

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

556

0.93

0.16

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.13

0.16

1.4

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

596

1.06

0.14

1.1

—

(3027944) Amphetamines [Presence] in Urine

135

1303

1.04

0.14

2.4

2.2

—

(3020491) Glucose [Moles/volume] in Blood

314

1.08

0.14

2.6

1.9

7.4

6.6

mmol/l

0.81

217

(3002523) Influenza virus A Ag [Presence] in Specimen

597

1.06

0.13

1.1

—

(44806420)

128

0.86

0.13

2.2

2.4

—

(3004775) Volume in Urine collected for unspecified duration

383

1.07

0.13

2.7

2.2

683.0

624.4

0.34

248

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

356

0.93

0.13

1.4

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

180

0.89

0.13

4.5

2.3

—

(3020650) Glucose [Presence] in Urine

113

1.15

0.13

1.6

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

171

1.11

0.12

1.7

2.3

6012.2

4983.4

e6/l

0.05

126

(3051593) INR in Capillary blood by Coagulation assay

210

0.90

0.12

21.6

11.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

163

1585

1.03

0.12

3.2

3.5

1540.4

3586.8

u/ml

0.43

136

1362

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

385

1.07

0.12

1.3

1.4

27.0

138.3

pmol/l

0.84

121

(3047189) Immunofixation for 24 hour Urine

220

1.09

0.11

3.2

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

299

1.07

0.10

2.0

1.6

—

(3016879) Cocaine [Presence] in Urine

127

1235

1.03

0.10

2.4

2.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

712

1.04

0.10

1.1

4.0

2.2

u/ml

0.40

305

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.06

0.09

1.0

—

(4211845)

227

0.92

0.09

3.6

3.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.13

0.09

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.07

0.08

2.3

2.7

—

(3033799) Differential panel - Peritoneal fluid

154

0.91

0.08

1.4

2.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.86

0.07

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.07

0.07

1.9

2.1

11.8

16.7

umol/l

—

(3051101) Glucose [Moles/volume] in Cord blood

1.05

0.07

1.9

6.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.03

0.07

1.3

1.1

—

6.3

pmol/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.03

0.07

1.4

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

630

1.03

0.06

1.1

6.3

5.0

u/ml

0.28

338

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

173

0.92

0.06

1.9

3.1

—

(3000330) Specific gravity of Urine by Test strip

217

2200

0.99

0.06

4.1

3.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

335

0.95

0.06

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

120

1.08

0.04

1.8

1.9

—

(3022689) Creatine [Moles/volume] in Urine

130

1.08

0.04

1.7

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

130

1.08

0.04

10.4

7.5

—

(3023410) Appearance of Cerebral spinal fluid

417

1.03

0.04

2.0

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

574

0.98

0.04

1.1

1.5

2.1

u/ml

0.29

142

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

523

0.97

0.04

1.4

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

189

0.95

0.03

1.3

1.0

6.1

0.6

u/ml

—

(40768795) Lymph node Pathology biopsy report

410

0.98

0.02

1.3

1.2

—

(1002224) Polysomnography panel

173

1719

1.01

0.01

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

342

3407

1.00

0.01

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

153

1.05

0.01

1.6

2.0

8385.7

16141.5

e6/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

532

1.02

0.01

1.1

1.3

7.2

7.4

mmol/l

0.13

393

(3014133) Dog dander IgE Ab [Units/volume] in Serum

473

1.01

0.01

1.0

1.1

3.1

2.9

u/ml

0.08

199

(3020874) Milk IgE Ab [Units/volume] in Serum

194

1.03

0.00

1.1

1.0

44.4

0.8

u/ml

0.46

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

336

0.98

0.00

2.2

2.0

1.3

1.9

u/field

0.45

128

(3008401) Mugwort IgE Ab [Units/volume] in Serum

616

0.99

0.00

1.1

1.2

u/ml

0.06

282

(3038071) Oxygen [Partial pressure] in Mixed venous blood

115

1.04

0.00

11.1

7.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

315

0.98

0.00

1.2

1.3

—

(4024509)

395

1.01

0.00

1.6

1.5

—

(4198724)

164

0.98

0.00

1.8

3.0

—

(4133840)

113

0.97

0.00

1.5

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

177

1.02

0.00

1.6

8.2

8.1

mmol/l

—

109

(3015183) Erythrocyte sedimentation rate

191

0.99

0.00

1.4

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

108

1079

1.00

0.00

1.4

1.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1577.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.98

0.00

1.6

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(40762365) Oxygen content in Arterial blood by calculation

1.00

0.00

2.4

3.3

15.3

15.0

ml/dl

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.4

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.4

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.96

0.00

1.0

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_DERMATOPHYTOSIS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_DERMATOPHYTOSIS	1.662 [1.49, 1.85]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 2070 out of 10637 females with AB1_DERMATOPHYTOSIS died.

Males

Parameter	HR [95% CI]	p-value
AB1_DERMATOPHYTOSIS	1.583 [1.43, 1.75]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 3119 out of 13738 males with AB1_DERMATOPHYTOSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_DERMATOPHYTOSIS.

N-year risk	Females	Males
1	0.116%	0.267%
5	0.782%	1.751%
10	1.971%	4.39%
15	3.475%	8.116%
20	6.162%	13.442%

Relationships between endpoints

↥

Index endpoint: AB1_DERMATOPHYTOSIS – Dermatophytosis

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dermatophytosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints